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ABSTRACT
The complexity of cellular environments presents a challenge to efforts at studying
and elucidating biomolecules in cells. Covalent ligation of biomolecules with fluorescent
molecules that have a reactive functional group that can react with a complementary
functional group on biomolecules is one way that has been utilized to study biomolecules.
It enables visualization and tracking of ligation and transportation of molecules within the
cell. However, the myriad of functional groups within the cell makes achieving selectivity
difficult. To circumvent this problem, reactions that do not interfere with biology have been
developed. These reactions, referred to as bioorthogonal reactions must be rapid, selective
to the reactive species in the cellular environment and non-toxic to the cells. In Chapter 1
of this work, we discussed some of the key reactions developed to date and their
applications in bioconjugation.
In Chapter 2, we investigated the regioselectivity of secondary amine-catalyzed
inverse electron demand Diels-Alder reaction (iDA) of unsymmetrical tetrazines with
aldehyde or ketones. Only one regioisomer was observed for the reactions of the
unsymmetrical tetrazines with aldehydes and ketones. In addition, fluorogenic dyes were
developed with tetrazine as the “triggering group”. The reaction was amenable to aqueous
environment and hence was used to label aldehydes in cells.
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In Chapter 3, a quartz crystal microbalance (QCM)-based sensor for detecting
aldehydes was developed. By immobilizing graphene followed by 1,8-diaminonapthalene
(DAN) on a QCM chip, a sensitive and facile aldehyde and ketone sensor was developed.
The binding of the aldehydes to the DAN on the QCM chip resulted in a decrease in the
fundamental resonant frequency of the functionalized QCM chips. The magnitude of the
frequency change is directly proportional to the mass added. The utility of the probe for
labeling biomolecules was demonstrated by using as a sensor for sialic acids pretreated
with sodium periodate at mild conditions. In addition, the sensor was used to detect sialic
acid on a sialoprotein and on bone marrow mesenchymal stem cells.
In Chapter 4, pyrene-anchored boronic acids were designed, synthesized and
subsequently used to label glycans on cells. The boronic acids bound to the diols of glycans
whiles pyrenes allowed for fluorescence imaging and tracking of the molecule in the cell.
We observed the binding of the boronic acids to the glycans allowed for transport of the
pyrene-anchored boronic acids into the cytoplasm of the cell.
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CHAPTER 1
INTRODUCTION TO BIOCONJUGATION REACTIONS
1.1 Bioconjugation and Click Chemistry
Bioconjugation is the process of forming a stable covalent linkage between two or
more molecules of which at least one is a biomolecule, or an engineered biomolecule.1
However, the complex nature of biological environments, such as in the cell, makes
selectively targeting a biomolecule for conjugation to another molecule daunting. To
achieve selective bioconjugation in cells, the chemistry for linking a biomolecule to
another, or to an organic molecule, ought to be inert to the myriad of reactive species within
the cellular environment. Therefore, only very few known reactions have proved adaptable
for such purpose.2,3
Since functional groups required for selective or bioorthogonal reactions are mostly
not in the list of functionalities found in biomolecules, the method of biolabeling requires
the introduction of a functional group into the biomolecule. This is often achieved by
metabolic incorporation of an unnatural substrates. The modified substrates can
subsequently be ligated using their complimentary functional groups.
In 2001, Sharpless introduced the term “Click Chemistry”, and defined a set of
stringent criteria that reactions must meet to be included in the scope 4 He averred that such
reactions must be modular, wide in scope, give very high yields, generate only inoffensive
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by products that can be removed by nonchromatographic methods, and be stereospecific.
In addition, the reaction must proceed in no solvents or easily removable and benign
solvents, including water; and must be compatible with physiological conditions.4 The
quintessential click reaction, the copper (I)-catalyzed azide-alkyne reaction, was
discovered concurrently and independently by the groups of Sharpless/Fokin and
Mendel.5,6 The reaction was a modification and an improvement of the Huisgen 1,3-dipolar
cycloaddition reaction discovered in the early 1960s.7 Whereas the original Huisgen’s
reaction requires high temperatures to occur and affords both 1,4- and 1,5-disubstituted1,2,3-triazole,7,8 the copper(I)-catalyzed azide-alkyne reaction, proceeds at room
temperature

and

gives

only the

1,4-disubstituted-1,2,3-triazole

However,

the

thermodynamic instability of Cu(I) was a major drawback for the reaction as its easily
oxidizes to Cu(II) or disproportionates to Cu (0), limiting the reaction to inert environments
and anhydrous solvents for optimal yield. To circumvent this, copper(I)-stabilizing ligands
were developed to improve the process. Fokin, Sharpless and coworkers designed
oligotriazole ligands for stabilizing the Cu(I), and tested them using a model reaction
between phenylacetylene and benzyl azide with 1 mol% Cu(I) and 1 mol% ligand in 2:1 tBuOH:H2O (Scheme 1). Improved reactivity was observed for the ligand-stabilized Cu(I)
reactions, with tris((1-benzyl-1H-1,2,3-triazol-4-yl)methyl)amine (TBTA) being the best
ligand. The TBTA appeared to tightly bind Cu(I), thereby stabilizing it from oxidation to
Cu(II) as confirmed by cyclic voltammetry.9
The excellent reaction profiles of the ligand-stabilized Cu(I) mediated azide-alkyne
reaction has made the reaction an important tool in bioconjugation. Many elegant “click”
ligation of biomolecules in vitro and in cell lysates have been reported, but the toxicity of
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copper-ligand complexes have for most part precluded the applications in vivo. For
example, E coli cells that incorporated azidohomoalanine in their outer membrane protein
opmC were labeled using 100 µM CuBr for 16 h and survived, but were no longer able to
divide afterwards.10,11 Similarly, mammalian cells survived treatment with 500 µM of
Cu(I) for 1 h, but greater than 90% of the cells underwent apoptosis when Cu(I)
concentration was increased to 1 mM under optimized conditions.1,12 Zebra fish embryos
also displayed similar sensitivity to Cu(I). All the embryos were dead within 15 minutes
after treatment with 1 mM CuSO4, 1.5 mM sodium ascorbate and 0.1 mM TBTA ligand.1
.Although copper-binding ligands were later discovered, such as the BTTES by Wu and
coworkers,13 and L-Histidine by Pezacki and coworkers,14 which render the copper benign
to cells, a lot more researchers prefer metal-free methods for bioconjugation
(a)

(b)

Scheme 1.1. (a) Copper(I)-catalyzed azide-alkyne cyclization (CuAAC) reaction. (b)
Ligands of CuAAC reactions.
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1.2 Strained alkynes
The strain-promoted azide-alkyne cycloaddition (SPAAC) reaction was developed
to meet the demand for a metal-free alternative to the CuAAC reaction. This became
imperative at the time when the existing copper-ligand complexes were considered toxic
to cells. Inspired by the work of Wittig and Krebs who reported that cyclooctyne, the
smallest stable cycloalkyne reacted “like an explosive” with phenyl azides (Scheme 1.2a).15
Bertozzi and coworkers synthesized biotin conjugates with cyclooctynes and reported that
it labeled azides efficiently within cell-surface glycans without any apparent toxicity to the
cells.16 The improved reactivity of the azide with cyclooctyne over that of linear alkynes is
due to the release of ~ 18 kcal/mol ring strain associated with the cyclooctyne in the
transition state of the cycloaddition. However, the second order reaction rate of the strainpromoted azide-alkyne [3+2] cycloaddition of this first generation cyclooctyne was only
0.0024 M-1 s-1, which is lower than that of normal CuAAC reaction.17 Additionally, the
compound also had limited water solubility.
The lowest unoccupied orbital (LUMO) of the cyclooctyne is lower in energy
relative to the linear alkynes due to the intrinsic ring strain of the former. This leads to a
better overlap between the LUMO of the alkyne and the highest occupied molecular orbital
(HOMO) of the azide.18,19 To further lower the LUMO of the alkynes and improve the
reaction rates, Bertozzi and coworkers synthesized and investigated the reactivity of
cyclooctynes substituted with electron-withdrawing fluorines on the propargyl carbon
(Scheme

1.2b).

Relative

to

the

first

generation

unsubstituted

cyclooctynes,

monofluorinated cyclooctyne (MOFO) demonstrated a 4-fold increase in reactivity with
azides,18 whiles the gem-difluorinated (DIFO) had a dramatic 60-fold increase.19 The gem-
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difluorinated DIFO also has a good water solubility and a second order rate constant similar
to CuAAC reaction in biomolecule labeling, earning it the name “Copper-free click
reaction”.19
These findings inspired investigations into other substituted cyclooctynes. Boons
and co-workers reported that fusing two aryl rings to the cyclooctyne core resulted in a
highly strained cyclooctyne (DIBO,) with a rate constant similar to that of DIFO,20 whiles
Bertozzi group reported another magnitude increase in the reaction rate by addition of
amide bond to the DIBO scaffold to afford biarylazacyclooctyne (BARAC k = 0.96 M-1s1 21

). Other substituted cyclooctynes developed with remarkable second order rate constants

include, DIBAC or ADIBO,22,23 photocaged DIBO (PDIBO)24 and tetramethoxy versions
of DIBO (TMDIBO).25
The excellent reactivity of SPAAC and its nontoxicity spurred its application in
vivo. Bertozzi and coworkers employed DIFO-Alexa Fluor conjugates to label azido
sugars on cell surface of developing embryos26 and Caenorhabditis elegans.27 This was
achieved by first metabolically incorporating peracylated N-azidoacetylgalactosamine
(Ac4GalNAZ) into the zebra fish embryo or the C. elegans’ glycans. The peracylated
glycans passively diffused into the cells where they were deacylated by cellular esterases.
Consequently, the free sugars were processed and incorporated into newly synthesized
glycans, some of which were displayed on cell-surface glycoconjugates. The azido sugars
on the cell surface were then imaged by SPAAC chemistry using the cyclooctyne probes,
enabling visualization of the glycans in vivo. The developing zebra fish embryos were
imaged between 60 to 73 hpf, and dynamic labeling was monitored in the pectoral fins,
olfactory pit, and jaw. Glycan trafficking between 60 and 73 h was also analyzed through
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pulse-chase experiments with spectrally distinct glycoconjugates. Similar labeling was
observed in the pharynx, vulva, and anus when C. elegance were treated with DIFO-Alexa
Fluor conjugates after the incorporation of azido-glycans.27 Comparative study of a number
of cyclooctynes in vivo showed that the reactivity of the cyclooctynes in vivo depends on
the combined influence of intrinsic reactivity and bioavailability.28
(a)

(b)

Scheme 1.2. (a) Strained-promoted azide-alkyne reaction. (b) Typical strained
cyclooctynes and their second order rate constants for reaction with azides
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1.3 Reaction of azides with alkenes
Alkenes react with azides in a similar way as alkynes. However, the reactions of
azides with alkenes produce triazolines, which unlike the triazoles are unstable. The azidealkene reaction dates back to the 1930s when Alder and Stein reported that strain alkenes
such as norbornene and dicyclopentadiene reacted over hundred times faster than
unstrained alkenes.29,30 As expected, the low stability of the product, the triazolines,
precludes most strained alkenes from being used in bioorthogonal reactions with azides.
Nonetheless, Rutjes and coworkers reported that the use of oxanorbornadiene to
react with the azides produced stable aromatic triazoles (Scheme 1.3), and were able to
apply the reaction to selectively label an oxanorbornadiene-functionalized protein that had
been incorporated into a hen egg white lysoszyme. The reaction between azides and
oxanorbornadiene occured at the electron poor double bond to form a triazoline, which
further underwent a retro-Diels-Alder reaction to extrude furan, to produce a stable
aromatic triazole.

Scheme 1.3. Reaction of azide with oxanorbornadiene.
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1.4 Staudinger ligation
Staudinger ligation is a modification of an earlier discovered reaction, the
Staudinger reduction, which involves the reduction of azides with triphenylphosphine to
obtain amines and triphenylphosphine oxides (Schemes 1.4a).31 In Staudinger ligation, an
ester groups is strategically placed on an arylphosphine or phosphoniothioester to allow an
aza-ylide formed to undergo intramolecular reaction with the ester to form an amide bond
(Scheme 1.4b). The reaction of the aza-ylide with the ester is critical; otherwise, the azaylide would hydrolyze to form the corresponding amine and triaryllphosphine.32
The reaction has been successfully used in labeling biomolecules in vitro and in
vivo with no adverse effects.33-35 However, the Staudinger ligation suffers from slow
reaction kinetics and limited water solubility,32,36 which limits the scope of its application.
1.5 Photoinduced reaction of tetrazoles with alkenes
The photoinduced cycloaddition reaction between tetrazole and alkenes to form
pyrazolines takes advantage of the nitrile imine dipole generated during reversecycloaddition of diaryltetrazole to form a [3+2] cycloadduct with alkenes (Scheme 1.5).
This phenomenon was also first reported by Huisgen and coworkers. They observed that
2,5-diphenyltetrazole reacted with methylcrotonate under photoactivation to form a
pyrazoline.37 However, Lin and coworkers were the first to apply this reaction in
bioconjugation by incorporating o-ally tyrosine into a protein in E. coli and “clicking” with
tetrazole under 302 nm of light.38 The small size of the alkenes relative to norbornene or
cyclooctynes is the advantage of this method, but the irradiations at 302 nm is toxic to cells.
To circumvent this, new diaryltetrazoles were developed that can be activated by 365 nm
of UV light,39 and 405 nm laser light.40
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(a)

(b)

Scheme 1.4. (a) Mechanism of Classical Staudinger reaction. (b) Mechanism of Staudinger
ligation of azides with triarylphosphine.
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Scheme 1.5. Photoinduced reaction of diaryltetrazole with alkene.

1.6 Reactions of ketones and aldehyde
Aldehydes and ketones are, as a matter of fact, not exogenous to cells, as aldehydes
can be found in glucose and intracellular metabolites, and ketones in mammalian
hormones. Nonetheless, they have found utility in bioconjugation, and remain functional
groups of choice for bioconjugation reactions.2,41 They are absent from endogenous
biopolymers and are unreactive to functional groups found in protein, lipids and glycans.
The reaction of aldehydes or ketones with amines produces Schiff base. In aqueous
medium, the reaction is reversible, and in the case of primary amines the equilibrium favors
the carbonyl.35 To avoid rapid hydrolysis of the Schiff base, researchers have used α-effect
amines – hydrazines and aminoxy compounds – to ligate biomolecules tagged with
aldehydes or ketones.42,43 The reactions of hydrazines and aminoxy (also called
hydroxylamines) produce hydrazones and oximes respectively (Scheme 1.6a). Although
these are more stable than imines, they still have limitations as far as applications in vivo
is concerned. The reactions of the α-effect nitrogen with aldehydes or ketones is optimum
at slightly acid conditions (pH 5-6) due to the protonation of the carbonyl step involved
before the reaction with the amines. But lowering of the pH of the reaction mixture also
protonates the amines, rendering them less nucleophilic. High concentrations of the amines
have been used to circumvent the reactivity problem but quantitative labeling could not be
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achieved. Other researchers have used aniline as the catalyst to improve the reactivity via
transamination.44-46 The aniline reacts with the protonated carbonyls to form imines, which
remains protonated at the pH of the reaction, and consequently reacting with the aminoxy
or hydrazine reagent to form an oxime or hydrazone (Scheme 1.6b).
Another method of bioconjugation involving aldehydes is based on the PictetSpengler reaction between aldehydes and tryptamines.47 This method, which forms an
irreversible C-C bond between tryptamine and an aldehyde or a ketone was recently applied
to the ligation of biomolecules by Bertozzi and coworkers.47 In order to increase the rate
of the reaction, an alkoxyamine (α-effect amine) was used to react with an aldehyde to
form an intermediate oxyiminium ion, which subsequently underwent intramolecular
reaction with indole nucleophiles to form a stable oxacarboline product (Scheme 1.6c).
1.7 Diels-Alder reactions
Diels-Alder reaction is one of the methods that has been extensively used in
bioconjugation due to its efficiency, selectivity and compatibility with water. It typically
involves reacting an alkene (or a dienophile) with a diene. Alkenes and dienes are absent
from biological systems, except in lipids, and few hormones. Electron poor alkenes such
as maleimides have been used in bioconjugation reactions with dienes.48-50 However, this
reaction is not bioorthogonal since bio-thiols can react with maleimide via Michael
addition.51,52 Protection of thiol groups is therefore required to achieve selectivity with
these reactions. For example, Walder and his coworkers have used Ellman’s reagent to
protect cysteine of Rab 7 before ligating the dienes on the Rab 7 protein with a maleimide
via Diels-Alder reaction.53 The kinetics of Diels-Alder reaction is, however, slow and
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(a)

(b)

(c)

Scheme 1.6. Reactions of aldehydes/ketones with α-effect amines. (a) Reactions of
aldehydes/ketones with hydroxylamine or hydrazine to produce oximes or hydrazine
respectively. (b) Aniline-catalyzed oxime ligation. The aniline reacts with the carbonyl to
form imine, which subsequently reacts with the α-effect amine to form an oxime. (c) Pictet–
Spengler ligation of aldehydes with a modified tryptamine. The alkoxyamine reacted with
the carbonyl to form an imine, which subsequently underwent intramolecular reaction with
indole to form a stable product.
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generally requires high concentration of the substrates (greater than 1 mM) for successful
ligation.54
Another type of Diels-Alder reaction, the inverse electron demand Diels-Alder
reaction (iDA) with tetrazines as the diene, and alkenes or alkynes as the dienophiles has
been extensively used in bioconjugation recently.1,55 The kinetics of Diels-Alder reaction
of tetrazines with different alkenes and alkynes was extensively studied by Sauer and
coworkers in 1998.56 However, it was not until 2008 that Fox and coworkers reported the
first applications of iDA reaction in bioconjugation.57 By functionalizing the protein,
thioredoxin (Trx) with trans-cyclooctene, and reacting with dipyridyltetrazine in aqueous
medium, the iDA ligation product was obtained within 5 minutes. Subsequently Weisleder
and coworkers demonstrated the utility of the reaction in live cell imaging by pretargeting
cells with trans-cyclooctene bearing anti-EGFR antibody and labeling them with tetrazine
tethered to a fluorophore.58 They reported that the labeling was specific for cells treated
with trans-cyclooctene bearing anti-EGFR antibody and occurred primarily on the surface
of the cells where EGFR concentration is the highest.
In contrast to Diels-Alder reactions involving maleimides and dienes, the reaction
of tetrazines with trans-cyclooctene is exceptionally fast, with a rate constant of 2000 to
22000 M.s-1, which is far faster than SPAAC reactions.59,60 Other strained alkenes that have
since been used in bioconjugation reactions with tetrazines include norbornene,61 and
cyclopropane.62 However, the kinetics of these cycloalkenes are many orders of magnitude
lower than that of trans-cyclooctene.63
The Diels-Alder reactions of tetrazines, or other electron poor heteroatom dienes
with alkenes is known as inverse electron demand Diels- Alder reaction (iDA) because the
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dominant orbital interactions in the transition state (TS) of Diels-Alder reaction is reversed
for reactions involving electron poor dienes such as tetrazines. For normal Diels-Alder
reactions, the dominant interaction is between the HOMO of the diene and the LUMO of
the dienophiles. But for tetrazines and other electron poor dienes, it is the HOMO of the
dienophile (i.e. alkene) that interacts with the LUMO of the diene (i.e. tetrazine) Figure
(1.1).64,65 The iDA reaction with tetrazines proceeds in two steps: an inverse electrondemand Diels- Alder reaction, followed by a retro Diels-Alder reaction, which extrude
nitrogen to give the product (Scheme 1.7).
1.8 Conclusion
The reactions discussed herein represent key chemical transformations that have
been applied in bioconjugation. They have been used in direct labeling of biomolecules
such as nucleic acids, proteins, carbohydrates and lipids inside cells, and also in target
identification of bioactive small molecules, leading to great insights and fundamental
discoveries. Nonetheless, the biocompatibility of these chemical tags, such as toxicity,
selectivity, sensitivity and stability when they are present in biological environment still
needs further improvement. For example, the use of Cu(I) catalyst in CuAAC makes the
reaction unsuitable for animal studies and SPAAC was developed to meet the needs for
catalyst-free labeling. However, the size of the cyclooctynes used in SPAAC could lead to
perturbation of certain biomolecules. Tetrazine ligation with strained alkenes is also
achieved without catalyst, but the stability of the most reactive strained alkenes, transcyclooctene in biological media is not good enough. There is therefore a need to develop
new bioorthogonal reactions with improved reactivity and stability in biological media to
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add to the tool kit of reactions available for bioconjugation. This thesis discusses my efforts
in developing new reactions and methods for labeling biomolecules in cells.

(a) Normal Diels-Alder reaction

(b) Inverse Demand Diels-Alder reaction

Figure 1.1. Schematic of the dominant transition state interaction of orbitals of dienes and
dienophiles (up) and their representative energy levels (down) during Diels-Alder reactions
(a) Normal Diels-Alder reaction. The HOMO of the diene interacts with the LUMO of the
dienophile (b) Inverse Diels-Alder reaction. The HOMO of the dienophile interacts with
the LUMO of the diene.
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Scheme 1.7. The inverse electron demand Diels-Alder reaction of tetrazines with alkenes.
The reaction proceeds in two steps: an inverse electron-demand Diels-Alder reaction,
followed by a retro Diels-Alder reaction, which extrude nitrogen to give the product.
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CHAPTER 2
REGIOSELECTIVE INVERSE DIELS-ALDER REACTION OF
UNSYMMETRICAL TETRAZINES WITH ALDEHYDES AND
KETONES
2.1. INTRODUCTION
The reactivity of tetrazines and alkenes in inverse electron demand Diels-Alder
reactions (iDA) depends on the differences in energies between the lowest unoccupied
molecular orbital of the diene (HOMOdiene) and the highest occupied molecular orbital of
the dienophile (LUMOdienophile).1,2 Thus, one can easily improve the kinetics of the reaction
by either placing electron withdrawing groups on the 3,6-position of the tetrazine, or having
electron donating groups on the α-position of the dienophile. Most of the bioconjugation
reactions performed to date using iDA reactions have relied on strained alkenes or alkynes
since angle straines increase the HOMO energy level of the dienophiles and consequently
improve the kinetics of the iDA reactions.3-5 6 Each of the strained alkenes or alkynes used
for the reaction has it’s unique advantages, but trans-cyclooctene remains the most used
dienophile for iDA ligations due to its exceptional reactivity.1
Although trans-cyclooctene is very reactive and could easily react with most
tetrazines at room temperature with kinetics fast enough for biolabeling, it is unstable and
thus requires storage at subzero temperatures.7 Other strained alkenes such as norbornene,
cis-cyclooctene and cyclooctyne are more stable at room temperature but have low
reactivity relative to trans-cyclooctene, and in some instances do not react with some
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tetrazines at mild conditions needed for bioconjugation.8 There is therefore the need to
develop more reactive dienophiles for tetrazines ligation using reagents that are both stable
and having reactivity that is fast enough for bioconjugation
Sauer and coworkers studied the reaction of 1,2,4,5-tetrazine and electron rich
dienophiles, such as enamines, ynamines and enol ethers and found that enamines display
the fastest kinetics among non-strained dienophiles.2 However, the low stability of
enamines, especially in water greatly compromises their reactivity and potential
applications in bioconjugation. To circumvent this, Wang and coworkers used proline as a
catalyst to promote direct iDA reactions of ketones with tetrazines via the in situ formation
of the enamine intermediate (Scheme 2.1).9 The enamines underwent iDA reaction with
tetrazine followed by retro Diels-Alder reaction, which resulted in the loss of nitrogen
molecules. However, only symmetric tetrazines were tested in that study. In this work, we
report the regioselectivity of the direct iDA reaction of aldehydes and ketones with
unsymmetrical tetrazines as well as the potential application of the reaction in bioimaging.

Scheme 2.1. Reaction Pathway of secondary amine-catalyzed iDA reaction between
ketones/aldehydes and tetrazines.
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2.2 RESULTS AND DISCUSSION
2.2.0 Reactivity of tetrazines with in situ generated enamines.
Tetrazines, 2.1 - 2.4, (Figure 2.1) were synthesized according to the method by
Deveraj and coworkers with little modifications.10 whiles tetrazine 2.5 was synthesized by
first making dichlorotetrazine using procedure by Clavier and coworkers,11 followed by
reaction of the dichlorotetrazine with n-butylamine to obtain compound 2.5.12 Initial
screening of the iDA reaction of the tetrazines with in situ generated enamines using
hexanaldehyde and pyrrolidine showed that whiles tetrazines, 2.1, 2.2 and 2.4 reacted
easily leading to the disappearance of the purple color of the tetrazines, tetrazines 2.3 and
2.5 remained unreactive, even after stirring at 100 oC for 24 hours.

.
Figure 2.1. Tetrazines tested for iDA reactions.
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To further investigate the reactivity and regioselectivity of the secondary aminecatalyzed iDA reactions of unsymmetrical tetrazines with aldehydes and ketones, a
selection of secondary amines (A-D) was screened as catalysts for the reaction of 3-methyl6-phenyl-1,2,4,5-tetrazine (2.1) with hexanaldehyde (2.6). All the reactions proceeded
smoothly at room temperature to produce a single cycloadduct 2.7, in 45-95% yield. The
use of pyrrolidine or morpholine in acetonitrile or dichloromethane furnished the product
in 89-95% yield within 5 minutes (Table 2.1, Entries 1, 2, 4); whereas using diethylamine
took 15 minutes (Entry 5). When we replaced the secondary amines with proline, similar
yields were observed in DMSO (Entry 9-10), but no products were observed when other
solvents were used, even with heating. The use of acetonitrile and water (1:1) resulted in a
45% yield (Entry 3), and a significant amount of unidentified by-products. As control
reactions, by mixing the tetrazine with secondary amines in the absence of aldehydes or
ketones, we observed no product formation, but a gradual degradation of the starting
material over 24 hours. This was also confirmed by NMR, and by observing the
disappearance of the purple color of the tetrazine.
Using pyrrolidine as the catalyst, we studied the reactivity and regioselectivity of a
number of aldehydes and ketones with asymmetric tetrazines (2.1). NMR analysis of the
crude products taken after each reaction unambiguously confirmed the formation of a sole
isomeric product in each case (Table 2.2). Upon purification, single crystal analysis of
some of the products were obtained to further confirm their regioselectivity. Figure 2.2
shows the NMR spectra of the sole products obtained by reaction of the tetrazine with (a)
acetone and (b) propionaldehyde. Figure 2.3 shows the crystal structure of the product
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obtained by the reaction of the tetrazine with 3-phenylpropionaldehyde (Table 2.2, Entry
6).
Table 2.1. Regioselectivity of secondary amine-catalyzed iDA reaction of hexanaldehyde
with an unsymmetrical tetrazine.

Entry

R2NH

Solvent

Temperature

Time

Yield (%)

1

A

CH2Cl2

rt

5 min

95

2

A

CH3CN

rt

5 min

89

3

A

CH3CN:H2O

100 oC

24 h

45

(1:1)
4

B

CH2Cl2

rt

5 min

95

5

C

CH2Cl2

rt

15 min

94

6

D

CH2Cl2

rt

24 h

0

7

D

CH3CN

rt

24 h

0

8

D

toluene

100 oC

24 h

0

9

D

DMSO

rt

24 h

94

10

D

DMSO

100 oC

10 min

95
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Table 2.2. Pyrrolidine-catalyzed regioselective reaction of
3-methyl-6-phenyl-1,2,4,5-tetrazine (2.1) with aldehydes/ketones
Entry

Aldehyde/Ketone

Product

Yield (%)

1
99

2

99

3

94

4

98

5

95

6

89

7

No reaction
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ND

a

b
b

Figure 2.2. NMR spectra showing regioselectivity in iDA reaction of 3-methyl-6-phenyl1,2,4,5-tetrazine with acetone (a) and propionaldehye (b).
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Figure 2.3. (a) The amine-catalyzed iDA reaction of 3-methyl-6-phenyl-1,2,4,5-tetrazine
with phenylpropionaldehyde (b) Single crystal structures of the sole product obtained.
The regioselectivity of the products formed were consistent with what one would
expect according to the zwitterionic models of alignment of dienophiles with
unsymmetrical dienes during the Diels-Alder reaction.13 In this case, the transition state of
the intermediate favors placement of the secondary amine and the phenyl substituent of the
tetrazine on the same side (Scheme 2.2).
2.2.1 Oxidation of diols to aldehydes, enamine formation and iDA reaction in one pot
Since aldehydes can be generated from diols by oxidation with sodium periodate.1416

We envisaged that the iDA reactions of tetrazines could be extended to vicinal diols, by

first treating a mixture of tetrazine and a vicinal diol with sodium periodate, and
immediately adding a secondary amine to the reaction mixture. This would generate an
enamine that could subsequently undergo iDA reaction with the tetrazine. We selected two
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Scheme 2.2. Proposed mechanism of the regioselective reaction of unsymmetrical tetrazine with aldehydes/ketones.
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diols for the initial screening; 2,3-butanediol and 1,2-cyclohexanediol, and the reaction was
carried out in 50% acetonitrile in water. The reaction with 1,2-butanediol proceeded
smoothly to afford the desired pyridazine 2.8 in 80% yield after 18 hours of stirring at room
temperature, whereas the reaction with 1,2-cyclohexanediol afforded the desired product
2.9 in 33% after 48 hours of stirring (Scheme 2.3). However, the reaction did not work
with sialic acid and estriol, two known biomolecules containing diols.

Scheme 2.3. One pot oxidation of diols to aldehydes, enamine formation and iDA reactions.

2.2.3 Screening for stability of tetrazine and the reactivity of the amine-catalyzed iDA
reaction in water
Having advanced our standing on the reactivity of the tetrazines in base-catalyzed
iDA reactions, we proceeded to test the compatibility of our reactants in aqueous media.
Methylphenyltetrazine (2.1) was dissolved in 1-5 mM solutions of pyrrolidine in
DMSO:H2O (10%). After 48 hours, the purple color of tetrazines in pyrrolidine solution of
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3 mM or more disappeared while those in 1-2 mM solutions of tetrazine did not show any
change. This shows that the methylphenyltetrazine degrades in solutions at pyrrolidine
concentrations higher than 2 mM.
We further proceeded to screen the iDA reaction of the tetrazine with a number of
aldehydes or ketones, and different amines as shown in Figure 2.4. After 24 hours, the
wells with diethylamine or pyrrolidine showed complete conversion whereas morpholine
did not show any conversion when mixed with glucose and galactose. The iDA reactions
catalyzed by proline only showed conversion for hexanaldehyde and propionaldehyde, but
not the ketones, glucose or galactose. We therefore concluded that proline is the least
reactive of the secondary amines. We were however unable to characterize the product of
the reactions involving glucose and galactose.
2.2.4 Synthesis of fluorogenic tetrazines for bioimaging
Tetrazines are chromophores with absorption wavelengths between 500 and 600
nm.17 However, upon reaction with dienophiles, the absorption band within this
wavelength disapperars.17 This unique property, coupled with it exceptional reactivity
makes tetrazine both a quencher and a bioorthogonal reacter. Weisleder and coworkers
have demonstrated that this ability of a tetrazine to modulate fluorescence of dyes is due
mainly to Föster resonance energy transfer (FRET) between the fluorophore and tetrazine,
as only green- and red- emitting dyes show significant fluorescence quenching when
functionalized with tetrazines.18 The quenching effect is truncated once the tetrazine
undergoes iDA reaction to furnish the desired product, leading to restoration of the
fluorescence.19,20
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Figure 2.4. Combinatorial screening of amine-catalyzed iDA reaction of tetrazine with aldehydes and ketones. Aldehyde (K-1 and K-4)
worked better than ketone. Concentration of bases higher than 2 mM causes destruction of tetrazine.

To choose the appropriate dye for our fluorogenic tetrazines, the absorption spectra
for the tetrazine to be outfitted on a fluorophore were measured. Compound 2.4 showed
maximum absorption at 534 nm (Figure 2.5a) whereas compound 2.5 showed a maximum
absorption at 514 nm (Figure 2.5b). We therefore chose to synthesize naphthalimidetetrazine conjugates as our bioorthogonal fluorogenic reactors since naphthalimide dyes
have maximum emissions at wavelengths within the range of our tetrazines (Figure 2.5c).
They also have large Stokes shifts, and high photostability, making them fluorophores of
choice for biolabeling experiments.21
Fluorogenic naphthalimide-tetrazine dyes 2.11 and 2.13 were therefore prepared.
Naphthalimide-tetrazine, 2.11 was synthesized by addition of dichlorotetrazine to the
amine terminal of naphthalimide dye 2.10 (scheme 2.4a) whiles 2.13 was synthesized by
EDCI and NHS mediated coupling of 2.4 to the amine terminal of 2.10 (Scheme 2.4b).
Significant quenching of the naphthalimide dye was observed after functionalization with
each of the tetrazine compounds.
Upon addition of stoichiometric amounts of phenylpropionaldehyde and
diethylamine to each dye in dichloromethane, the naphthalimide-tetrazine dyes underwent
iDA reactions to furnish fluorescent compounds. The fluorescence turn on ratios for 2.11
was 600 folds, whiles that of 2.13 was only 18 folds (Figure 2.5). This observation is most
likely due to the fact that, the n-butylchlorotetrazine dye’s (.2.5) maximum absorption
wavelength of 514 nm is closer to the naphthalimide dye’s maximum emission wavelength
of 507 nm than the tetrazine benzoic acid (2.4). Another factor that could have influenced
the quenching efficiency of the dyes by the tetrazines is the distance between the
naphthalimide and tetrazines linked together. Since the distance between the dye and
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tetrazine for 2.11 is shorter than that of 2.13, it is expected that a more effective quenching
effect, and a higher turn on ratio would be observed for 2.11 than 2.13.
NMR

and

MS

analysis

of

the

product

of

the

iDA

reaction

of

phenylpropionaldehyde with 2.11 showed the elimination of the amine to produce
pyradizine did not occur in this instant, which could be due to relative stability of the
dihydropyridazine of 2.12 over that of 2.14 and the methylphenyltetrazine (2.1).
2.2.5 Application of the fluorogenic naphthalimide-tetrazine dye in bioimaging
To evaluate the utility of the fluorogenic naphthalimide-tetrazine dyes in imaging
aldehyde containing biomolecules in cells, biotin aldehyde (50 µM), base (proline or
pyrrolidne) (100 µM) were incubated with bone marrow stroma cells (BMSCs) in primary
media for 2 hours, after which the cells were washed and the dye, 2.13 (10 µM) added to
the cells in a new media. After 1 hour, the cells were washed again to remove non-binding
dyes and visualized under fluorescence microscope. Scheme 2.5 shows the expected iDA
reaction of the naphthalimide tetrazine (2.13) and biotin-aldehyde (2.18)
Nonspecific binding of the dye to the cells, leading to high fluorescence images
were observed in the cells, including those without biotin and a base. Nonetheless,
comparing the fluorescence intensity of the six different wells containing different
combinations of the dye 2.13, a base and a biotin aldehyde (2.18) showed the wells with
all the three reagents (Figure 2.7, Exp 2 and Exp 3) showed 30-35% increase in
fluorescence intensity relative to the wells with 2.13 but lacking either the base or the biotin
aldehyde 2.18. The increase in the fluorescence intensity is a confirmation of ligation of
2.13 to the biotin aldehyde. It is expected that an appropriate dye, and a longer reaction
time will show a higher turn on ratio for the amine-catalyzed iDA ligation.
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Figure 2.5. (a, b) Absorption spectra of tetrazines 2.5 showing maximum absorption at 514
nm, (a), and 2.4 showing maximum absorption at 534 nm (b). (c) The fluorescence
emission spectrum of naphthalimide dye 2.10.
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(a)

.

(b)

Scheme 2.4. Synthesis of fluorogenic naphthalimide-tetrazine dyes 2.11 and 2.13.
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Figure 2.6. (a) Emission spectra of naphthalimide-tetrazine 2.11 (10 µM) (black) and the
corresponding iDA product, 2.12 (red) in CH2Cl2 (b) Emission spectra of naphthalimideamide tetrazine 2.13 (10 µM) (black) and the corresponding iDA product 2.14 (red).
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.

Scheme 2.5. Expected reaction of biotin-aldehyde (2.18) with tetrazine 2.13.
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Figure 2.7. Application of fluorogenic tetrazine 2.13 in imaging aldehyde-containing molecules in cells.(a) Cells incubated with biotin
aldehyde (50 µM) and/or an amine (100 µM); (b) Fluorescent confocal micrograph of cells after addition of dye, 2.13 (10 µM) (c)
Corresponding fluorescent intensity of cells after treatment with 2.13. Cells incubated with biotin aldehyde and proline (Exp 2); and
biotin aldehyde with pyrrolidine (Exp 3) showed higher fluorescent intensity than cells incubated with only biotin (Exp 1), proline (Exp
4) or pyrrolidine (Exp 5). Cells in Exp 6 were incubated without biotin or base prior to addition of 2.13.

2.3 CONCLUSION
We have established the regioselectivity of secondary amine-catalyzed iDA reaction with
unsymmetrical tetrazines such as 3-methyl-6-phenyl-1,2,4,5-tetrazine. The mechanism for
the regioselectivity was established to be directed by the alignment of the tetrazine and the
enamine formed in-situ at the transition state of the iDA reaction; a model which could be
used to predict the regioselectivity of the reaction with other unsymmetrical tetrazines. The
IDA reaction of tetrazines with vicinal diols was also demonstrated, but this reaction was
slow and may not be applicable in cells. The application of the reaction in tuning the
fluorescence of fluorogenic dyes having a tetrazine motif was demonstrated, as well as the
potential for bioconjugation and imaging molecules containing aldehydes or ketones. The
labeling of aldehyde in cells resulted in high background fluorescence. We surmised that
this could be due to the hydrophobicity of the dye. It is expected that the use of a
hydrophilic dye will result in very low or no unspecific labeling, which will make the
reaction more suitable for cell imaging.
2.4 EXPERIMENTAL SECTION
General. Unless otherwise specified all reagents and solvents were of commercial grade.
NMR spectra were recorded on Bruker 300 or 400 instruments. Flash column
chromatography was performed with silica gel (32-63 μm). High resolution mass
spectrometry (HRMS) was obtained using a magnetic sector mass spectrometer.
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To a 10 mL sealed tube equipped with a stir bar was added Nickel(II)
trifluoromethanesulfonate

(100 mg, 0.3 mmol), benzo nitrile (103 mg, 1.0 mmol),

acetonitrile (0.52 mL, 10.0 mmol) and anhydrous hydrazine (1.6 mL, 50 mmol). The vessel
was sealed and the mixture was stirred in an oil bath at 60° C for 24 hours. After reaction,
the mixture was cooled to room temperature and the seal was removed. Sodium nitrite (1.3
g, 20 mmol) in water (10 mL) was slowly added to the solution and followed by slow
addition of 1 N HCl during which the solution turned bright red in color and gas evolved.
Addition of 1 N HCl continued until gas evolution ceased and pH ~ 3. The mixture was
extracted with ethyl acetate (20 x 2) and the organic phase dried over sodium sulfate. The
solvent was removed using rotary evaporation and the residue purified using silica column
chromatography with dichloromethane:hexane (1:1) as eluent to obtain 3-methyl-6phenyltetrazine (2.1) (85mg, 49%) and a trace amount of dimethyltetrazine (2.3) (<5%)
3-Methyl-6-phenyltetrazine (2.1). 1H NMR (300 MHz, CDCl3): δ 8.70–8.45 (m, 2H),
7.73–7.50 (m, 3H), 3.10 (s, 3H). 13C NMR NMR (75 MHz, CDCl3): 167.2, 164.2, 132.5,
131.7, 129.2, 127.8, 21.1
3,6-Dimethyltetrazine (2.3). 1H NMR (300 MHz, CDCl3): δ 3.04 (s, 6H)

45

To a 10 mL sealed tube equipped with a stir bar was added Nickel(II)
trifluoromethanesulfonate (100 mg, 0.3 mmol), 3-cyanobenzoic acid (103 mg, 1.0 mmol),
acetonitrile (0.52 mL, 10.0 mmol) and anhydrous hydrazine (1.6 mL, 50 mmol). The vessel
was sealed and the mixture was stirred in an oil bath at 60 °C for 24 hours. After reaction,
the mixture was cooled to room temperature and the seal was removed. Sodium nitrite (1.3
g, 20 mmol) in water 10 mL was slowly added to the solution and followed by slow addition
of 1N HCl during which the solution turned bright red in color and gas evolved. Addition
of 1 N HCl continued until gas evolution ceased and pH ~ 3. The mixture was extracted
with ethyl acetate (20 x 2) and the organic phase dried over sodium sulfate. The solvent
was removed using rotary evaporation and the residue purified using silica column
chromatography to obtain titled compound 2.4 (200 mg, 46%)
1

H NMR (400 MHz, DMSO): δ 13.34 (s, 1H), 9.00 (d, J = 12.5 Hz, 1H), 8.68 (d, J = 7.9

Hz, 1H), 8.22 (d, J = 7.9 Hz, 1H), 7.93–7.71 (m, 1H), 3.11–2.90 (m, 2H). 13C NMR (101
MHz, DMSO): δ 167.84, 167.07, 133.30, 132.84, 132.34, 131.87, 130.40, 128.47, 21.33.
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To a 10 mL sealed tube equipped with a stir bar was added Nickel(II)
trifluoromethanesulfonate (100 mg, 0.3 mmol), benzo nitrile (103 mg, 1.0 mmol),
anhydrous hydrazine (1.6 mL, 50 mmol). The vessel was sealed and the mixture was stirred
in an oil bath at 60° C for 24 hours. After reaction, the mixture was cooled to room
temperature and the seal was removed. Sodium nitrite (1.3 g, 20 mmol) in water 10 mL
was slowly added to the solution and followed by slow addition of 1N HCl during which
the solution turned bright red in color and gas evolved. Addition of 1 N HCl continued
until gas evolution ceased and pH ~ 3. The mixture was extracted with ethyl acetate (20 x
2) and the organic phase dried over sodium sulfate. The solvent was removed using rotary
evaporation and the residue purified on silica column chromatography using
dichloromethane:hexane (1:1) as eluent to obtain to obtain compound 2.2 (95 mg, 41%) 1H
NMR (300 MHz, CDCl3): δ 8.85–8.6 (m, 2H), 7.78–7.58 (m, 3H).
CDCl3): 163.9, 132.7, 131.8, 129.3, 127.9.
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13

C NMR (75 MHz,

Synthesis of dichlorotetrazine11

Triaminoguanidine hydrochloride (2.19). To a slurry of guanidine hydrochloride (19.1g,
0.20mol) in 1,4-dioxane (100mL) was added hydrazine monohydrate (34.1g, 0.68mol)
with stirring. The mixture was heated under reflux for 2 hours. After the mixture cooled to
ambient temperature, the product was collected by filtration, washed with 1,4-dioxane, and
dried to give (27 g, quantitative) of pure triaminoguanidine monohydrochloride. 13C NMR
(D2O, 75MHz) δ= 160.5 ppm.
3,6-Bis(3,5-dimethyl-1-H-pyrazol-1-yl)-1,2-dihydro-s-tetrazine (2.20). To a solution of
triaminoguanidine monohydrochloride (27.0g, 0.19 mol) in water (150 mL) was added 2,4pentanedione (39.4 mL, 0.38 mol) dropwise with stirring at room temperature for 0.5 h.
The mixture is then heated to 70 °C and stirred for 4 hours, during which time solid
precipitated from solution. The mixture was cooled to room temperature, filtered, washed
with cold water and dried to obtain the product as a yellow solid (10.1 g, 20%) 3,6-Bis(3,5dimethylpyrazol-1-yl)-1,2-dihydro-s-tetrazine. 1H NMR (300 MHz, CDCl3): δ 8.09 (br s,
2H), 5.95 (s, 2H), 2.47 (s, 6H), 2.21 (s, 6H). 13C NMR (75MHz, CDCl3): δ 14.9, 148.5, 1,
142.3, 109.8, 13.7, 13.4.
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3,6-Bis(3,5-dimethyl1H-pyrazol-1-yl)-s-tetrazine (2.21). Sodium nitrite (7.1 g, 0.1 mol)
was dissolve in of water (100 mL) and CH2Cl2 (20 mL) was added. The mixture was kept
on ice and 3,6-bis(3,5-dimethylpyrazol-1-yl)-1,2-dihydro-s-tetrazine (10.1g, 0.036 mol)
was added batches. Acetic acid (9.3 mL, 0.16 mol) was added dropwise. Gas evolution
occurred, after which the organic layer was separated and the aqueous layer was extracted
with CH2Cl2 (3 x 20mL). The organic layers were combined, washed to neutrality with a
5% aqueous solution of potassium carbonate, dried over anhydrous sodium sulfate and
filtered. The solvent was removed in vacuo to obtain a dark red solid, which was washed
several times with diethyl ether time to obtain a brick red solid (8.2g 82%) as the titled
compound 1 H NMR (300 MHz, CDCl3): δ 2.39 (s, 6H), 2.72 (s, 6H), 6.20 (s, 2H).

13

C

NMR (75 MHz, CDCl3): δ 13.9, 14.7, 111.9, 143.8, 154.5, 159.3.
3,6-Dihydrazinyl-s-tetrazine (2.22). To a slurry of 3,6-bis(3,5-dimethylpyrazol-1-yl)-stetrazine (8.2 g, 0.03 mole) in acetonitrile (50 mL), was added hydrazine monohydrate (2.4
mL, 0.06 mol) dropwise at room temperature. The mixture was refluxed for 30 minutes
and cooled to room temperature. The mixture was filtered and washed with acetonitrile to
provide a black powder, 4 g, which was used for the next step without further purification
3,6-Dichloro-s-tetrazine (2.23). To a slurry of 3,6-di(hydrazino)-1,2,4,5-tetrazine (3.5 g,
0.025 mol) in acetonitrile (100 mL) at 0 oC was added in batches trichloroisocyanuric acid
(11.4 g, 0.05 mol) over 30 minutes. After the addition, the mixture was allowed to warm
to room temperature and stirred further for 30 minutes. White insoluble precipitate formed
was removed by filtration and the solvent removed in vacuo to give crude 3,6-dichloro-stetrazine which was purified on silica column using hexane to obtain orange crystals (1.05
g, ). 13C NMR (75MHz, CDCl3): δ 168.1.
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6-Butylamino-3-chlorotetrazine (2.5).12 Dichlorotetrazine (442.5 mg, 2.95 mmol) was
dissolved in CH2Cl2 (30 mL) and stirred before N-butylamine (0.5 mL, 5.06 mmol) was
added dropwise over 2 h. The resultant mixture was stirred at room temperature for another
2 h. The solvent was removed and the residue purified on flash column using
CH2Cl2:hexane (1:2-2:1) gradient to obtain a red product (425 mg, 77%). 1H NMR
(300MHz, CDCl3): 3.60 (q, J = 6.0 Hz, 2H), 1.77-1.63 (m, 2H), 1.52-1.38 (m, 2H) 0.97 (t,
J = 7.5, 3H) 13C NMR (CDCl3, 300MHz): 161.1, 160.0, 41.4, 30.9, 19.9, 13.6.
Typical procedure for secondary amine catalyzed inverse electron-demand Diels-Alder
reactions with aldehyde or ketones (Table 2.2).
A mixture of 3-methyl-6-phenyl-1,2,4,5-tetrazine (20 mg, 0.12 mmol), aldehyde or ketone
(0.24 mmol) and pyrrolidine (0.6 mg, 0.12 mmol) in CH2Cl2 (5 mL) was stirred at room
temperature for 30 minutes. After removal of the solvent in vacuo, the crude product was
purified by chromatography on silica to afford the desired product.
3-Methyl-6-phenylpyridazine (1).26 1H NMR (400 MHz, CDCl3): δ 8.06 – 8.04 (m, 2H),
7.75 (d, J = 8.7 Hz, 1H), 7.53–7.46 (m, 3H), 7.38 (d, J = 8.7 Hz, 1H), 2.73 (s, 1H). 13C
NMR (100 MHz, CDCl3): δ 158.6, 157.2, 136.5, 129.8, 128.9, 127.2, 126.9, 123.9, 22.1;
HRMS (EI): m/z calcd for C11H10N2: 170.0846; found: 170.0844.
1-Methyl-4-phenyl-6,7-dihydro-5H-cyclopenta(d)pyridazine (2). Oil. 1H NMR (300
MHz, CDCl3): δ7.81 (d, J = 7.3, 2H), 7.52-7.39 (m, 3H), 3.13 (t, J = 7.2, 2H), 2.96 (t, J =
7.2, 2H), 2.6 (s, 3H), 2.21-2.07 (m, 2H).

13

C NMR (100 MHz, CDCl3): δ 156.4, 155.7,
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143.9, 141.6, 137.3, 128.9, 128.5, 128.4, 32.9, 31.0, 29.7, 23.9, 19.9. HRMS (EI): calcd
for C14H14N2: 211.1235; found: 211.1231.
4,6-Dimethyl-3-phenylpyridazine (3). Off white solid. mp 80-82 oC. 1H NMR (400 MHz,
CDCl3): δ 7.57-7.53 (m, 2 H), 7.50-7.42 (m, 2H), 7.21 (s, 1H), 2.70 (s, 1H), 2.31 (s, 1H).13C
NMR (100 MHz, CDCl3): δ 160.1, 158.3, 137.1, 135.7, 219.1, 128.6, 128.4, 128.3, 21.8,
19.6; HRMS (EI): m/z calcd for C12H12N2: 184.100; found: 184.0995.
3,6-Dimethyl-6-phenylpyridazine (4).27 1H NMR (300 MHz, CDCl3): δ 8.04 (dd, J = 7.0,
0.6 Hz, 2H), 7.57 (s, 1H), 7.53-7.44 (m, 3H), 2.70 (s, 3H), 2.36 (s, 3H).

13

C NMR (100

MHz, CDCl3): δ 160.1, 158.2, 137.2, 135.7, 129.1, 128.7, 128.5, 128.3, 21.8, 19.6;
HRMS(EI): m/z calcd for C12H12N2: 184.100; found: 184.0995.
4-Butyl-3-methyl-6-phenylpyridazine (5). Light yellow oil. 1H NMR (400 MHz, CDCl3):
δ 8.04 (dd, J = 7.2, 0.7 Hz, 2H), 7.54 (s, 1H), 7.51-7.42 (m, 3H), 2.71 (s, 3H), 2.64 (t, J =
7.0 Hz, 2H), 1.68-1.58 (m, 2H), 1.50-1.38 (m, 2H), 0.98 (t, 7.3 Hz, 3H).13C NMR (100
MHz, CDCl3): δ 158.1, 157.7, 140.9, 136.7, 129.5, 128.9, 126.9, 123.1, 31.8, 30.6, 22.5,
19.7, 13.9; HRMS (EI): m/z calcd for C12H12N2: 226.1470; found: 226.1466.
4-Benzyl-3-methyl-6-phenylpyridazine (6). Off white solid. mp 128-133 oC. 1H NMR
(400 MHz, CDCl3): δ 7.99 (d, J = 6.3 Hz, 2H), 7.52-7.42 (m, 4H), 7.38-7.29 (m, 3H), 7.15
(d, J = 7.2, 2H), 4.02 (s, 2H), 2.7 (s, 3H).

13

C NMR (100 MHz, CDCl3): δ 158.2, 157.7,

140.89, 136.7, 129.5, 128.8, 126.9, 123.1, 31.7, 30.6, 22.5, 19.74, 13.9; HRMS (EI): m/z
calcd for C18H16N2: 260.1316; found: 260.1313.
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General procedure oxidation of the diols to aldehydes, enamine formation and IDA
reaction in one pot.
To a mixture of 3-methyl-6-phenyl-1,2,4,5-tetrazine (40.0 mg, 0.24 mmol), a 1,2-diol (0.24
mmol) in CH3CN:H2O was added NaIO4 (1 M, 300 µL). The mixture was stirred at room
temperature for 5 minutes, and pyrrolidine (0.6 mg, 0.12 mmol) was added. The mixture
was further stirred for 24 hours, diluted with water and extract into dichloromethane. The
organic layer was dried over sodium sulfate anhydrous and the solvent removed in vacuo.
The crude was purified by chromatography on silica to afford the desired product.
2.9 1H NMR (300 MHz, CDCl3): δ 8.14–7.93 (m, 4H), 7.58–7.44 (m, 8H), 3.03 (s, 6H),
2.87–2.72 (m, 4H). HRMS (EI): m/z calcd for C24H22N4: 366.1844; found: 366.1837.
Synthesis of naphthalimide dye 2.10

2.10. Following the literature procedure,22,23 a mixture of naphthalimide anhydride (1.0 g,
3.6 mmol) in ethanol (10 mL) and n-butylamine (1 mL, excess) was stirred at room
temperature overnight. A precipitate was formed, which was filtered, washed with ethanol
and dried in vacuo to obtain a white solid (725.0 mg, 60%). The intermediate (331 mg, 1.1
mmol) was refluxed in ethylenediamine (5 mL, excess) and heated to 80 oC for 6 h. The
mixture was cooled to room temperature, poured slowly unto ice and allowed to warm to
room temperature. A precipitate formed was filtered and dried to obtain a yellow solid
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(300.5 mg, 92%). 1H NMR (300 MHz, DMSO): δ 8.68 (d, J = 8.5 Hz, 1H), 8.40 (d, J = 7.2
Hz, 1H), 8.23 (d, J = 8.5 Hz, 1H), 7.65 (t, J = 7.8 Hz, 1H), 6.78 (d, J = 8.5 Hz, 1H), 3.99
(t, J = 7.3 Hz, 2H), 3.39 (dd, J = 26.4, 20.0 Hz, 5H), 2.83 (dd, J = 23.5, 17.1 Hz, 3H), 1.68
– 1.46 (m, 2H), 1.43 – 1.17 (m, 2H), 0.90 (t, J = 7.3 Hz, 3H).
NT-tetrazine 2.11. To compound 2.10 (104.6 mg, 0.34 mmol) in acetonitrile (10 mL)
dichlorotetrazine (50.5 mg, 0.34 mmol) and TEA (100 µL) were added. The reaction was
stirred at room temperature for 12 h. The product was poured in water (30 mL) and filtered
to obtain a dark red solid, which was purified by chromatography on silica using
CH2Cl2:CH3OH (10:0.1-10:0.5) gradient to obtain 10 as dark red solid (106 mg, 75%). mp
221-223 oC. 1H NMR (400 MHz, CDCl3): δ 8.44 (d, J = 8.0 Hz, 1H), 8.33 (d, J = 8.0 Hz,
1H), 8.02 (d, J = 8.0 Hz, 1H), 7.51 (t, J = 8.0 Hz, 1H), 7.07 (br s, 1H), 6.66 (d, J = 8.0 Hz,
1H), 6.63 (br s, 1H), 4.13-4.04 (m, 4H ), 3.77 (t, J = 7.1 Hz, 2H ), 1.70-1.60 (m, 2H ), 1.461.35 (m, 2H), 0.94 (t, J = 7.1 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ 164.5, 164.1, 161.9,
161.1, 148.9, 134.1, 131.2, 129.5, 126.0, 125.0, 122.9, 120.2, 110.8, 104.1, 43.7, 40.6, 40.1,
30.9, 30.2, 20.4, 13.9; HRMS (ESI): m/z (M+H) calcd for C20H20 ClN7O2: 426.1445; found:
426.1451.
NT-diazine (2.12). NT-tetrazine 2.11 (50.0 mg, 0.18 mmol) in dry CH2Cl2 (50.0 mg, 0.18
mmol) was mixed with phenylpropionaldehyde (15.8 mg, 0.18 mmol) and diethylamine
(18 µL, 0.18 mmol). The mixture was stirred at room temperature for 24 h and the solvent
removed in vacuo. The crude green fluorescent mixture was purified on silica gel column
with CH2Cl2:CH3OH (20:1) to obtain 2.11 as yellow solid (25 mg, 38%). mp 103-106 oC
1

H NMR (400 MHz, CDCl3): δ 8.57 (d, J = 8.3 Hz, 1H), 8.42 (d, J = 8.3 Hz, 1H), 8.32 (d,

J = 8.3 Hz, 1H), 8.21 (br s, 1H), 7.65 (t, J = 7.7 Hz, 1H), 7.14 (d, J = 7.0 Hz, 2H), 7.11-
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7.01 (m, 3H), 6.48 (d, J = 8.3 Hz, 1H), 4.15 (t, J = 7.5 Hz, 2H), 3.87 (s, 2H), 3.50 (brs, 2H),
3.29 (s, 1H), 3.06-2.95 (m, 1H), 2.89-2.80 (m, 1H), 2.55-2.45 (m, 2H), 2.41-2.29 (m, 2H),
2.19-2.04 (m, 2H), 1.77-1.64 (m, 2H), 1.52-1.37 (m, 2H), 0.96 (t, J = 7.1 Hz, 3H), 0.64 (t,
J = 8.0 Hz, 6H). 13C NMR (CDCl3, 100 MHz). δ 164.8, 164.4, 157.9, 150.4, 135.9, 134.4,
134.1, 129.7, 129.1, 128.8, 128.0, 127.3, 124.9, 122.6, 120.4, 109.5, 102.7, 43.1, 40.8, 39.7,
35.7, 30.1, 20.5, 13.9, 13.4; HRMS (ESI): m/z (M+H) calcd for C20H20ClN7O2: 587.2901;
found: 587.2896.
Naphthalimide-amidotetrazine 2.13: To tetrazine 2.4 (70.1 mg, 0.32 mmol) in CH2Cl2 (10
mL) was added EDCI (50.2 mg, 0.32 mmol) and N-hydroxysuccinimide (37.3 mg, 0.32
mmol). After 15 minutes of stirring, naphthalimide ethylenediamine (100.0 mg, 0.32
mmol) was added. THF (5 mL) was added to dissolve the dye and the reaction stirred at
room temperature for 20 h. The reaction mixture was further diluted with dichloromethane
and washed with water. The organic layer was dried over anhydrous sodium sulfate and
purified on silica column using dichloromethane to obtain the product (71.9 mg, 48%).
1

H NMR (400 MHz, DMSO): δ 9.0-9.03 (br s, 1H), 8.96-8.93 (br s, 1H), 8.74–8.56 (m,

2H), 8.41 (d, J = 6.8 Hz, 1H), 8.24 (d, J = 8.4 Hz, 1H), 8.16 (d, J = 6.8 Hz, 1H), 7.95 (s,
1H), 7.79 – 7.64 (m, 2H), 6.94 (d, J = 8.2 Hz, 1H), 4.03-3.94 (m, 2H), 3.69–3.60 (m, 4H),
3.02 (s, 3H), 1.61–1.51 (m, 2H), 1.37–1.23 (m, 2H), 0.91 (t, J = 7.2 Hz, 3H).13C NMR (101
MHz, DMSO): δ 167.83, 166.46, 164.14, 163.35, 151.06, 135.73, 134.57, 132.56, 131.46,
131.14, 130.46, 130.06, 129.82, 128.86, 126.55, 124.84, 122.30, 120.60, 108.27, 104.99,
104.23, 42.74, 38.59, 30.25, 21.35, 20.28, 14.20. HRMS (ESI): m/z calcd for C18H16N2:
510.2248; found: 510.2248.
Synthesis of biotin-aldehyde
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To a suspension of biotin 2.15 (244.0 mg, 1.0 mmol) in methanol (10 mL) was added a
drop of concentrated H2SO4. The mixture was stirred at room temperature till all the biotin
dissolved (72 h). The methanol was removed under vacuum to obtain a white precipitate
as the biotin ester (255 mg, quantitative).
To the biotin ester (258.5 mg, 1.0 mmol) in 10 mL of methanol was added ethylenediamine
(5 mL, excess) and the mixture stirred at 60 oC for 24 h. The methanol was removed under
vacuum and the remaining diamine removed by azeotropic distillation under vacuum using
methanol and toluene to obtain 2.16 as a yellow solid.24 1H NMR (300 MHz, CD3OD) δ
4.57–4.42 (m, 1H), 4.38–4.24 (m, 1H), 3.7-3.30 (m, 4H), 3.04–2.96 (m, 2H), 2.71 (d, J =
12.7 Hz, 1H), 2.39-2.14 (m, 2H), 1.84–1.55 (m, 4H), 1.52-1.34 (m, 2H).
2.17. To compound 2.16 (230 mg, 0.76 mmol) in dioxane 10 mL was added caprolactone
(86.6 mg, 0.7 mmol). The mixture was refluxed for 24 h and the solvent removed to obtain
a brown oil which was precipitate in diethyl ether and filtered to obtain 2.17 as brown solid,
which was used for the next step without further purification.
2.18. To compound 2.17 (300.0 mg, 0.75 mmol) in CH2Cl2 (4 mL) and DMSO (1 mL) was
added TEA (1 mL) followed by SO3.pyridine (190.0 mg, 1.5 mmol) in 4 portions over 20

55

minutes. The mixture was stirred at room temperature for 2 h, then poured into diethyl
ether. A yellow precipitate formed was filtered, washed with diethyl ether and dried to
obtain a brown solid (250.0 mg). 1H NMR (300 MHz, CDCl3) δ 9.39 (s, 1H), 4.36-4.01 (m,
2H), 3.47 (d, J =6.9, 1H), 3.38-3.08 (m, 7H), 2.75 (t, J = 7.5 Hz 2H), 1.73-1.58 (m, 2H),
1.54–1.12 (m, 12H).
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CHAPTER 3
QUARTZ CRYSTAL MICROBALANCE SENSOR FOR DETECTION OF
CELLULAR SIALIC ACIDS
3.1 INTRODUCTION
3.1.0 Sialic acids
Sialic acids represent a family of naturally occurring derivatives of the nine carbon
sugar, neuraminic acids, attached to the surfaces of cells’ proteins, glycans and lipids.1-4
They contribute to the structure and functional diversity of glycoproteins, glycolipids and
cells; and are important for a number of vital processes such as cell-cell interaction, cell
morphology, embryogenesis, development and in immune responses.5,6 Two classes of the
neuraminic acids exist, the N-acylated forms called the N-acetylneuraminic acids
(Neu5Ac), and the N-glycolated forms, known as the N-glycolylneuraminic acids
(Neu5Gc) (Figure 3.1a). The N-acetylneuraminic acids are the most ubiquitous of the two
groups, and almost the only ones found in humans, The N-glycolylneuraminic acids are
common in many animal species but are not found in humans, except in the case of a
particular kind of cancer. In addition to the N-substitutions, sialic acids can be Osubstituted at C-4, -7, -8, -9, linking acetyl, methyl, sulfate and phosphate groups onto the
molecule (Figure 3.1).7 On cell surfaces, sialation and desialation of glycoproteins are
controlled by sialytransferases and sialidases (also known as neuraminidases) respectively
to create equilibrium for proper cell functioning.8 A shift in this equilibrium has been
associated with various diseases such as cancer, cardiovascular and neurological diseases.2
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(a)

(b)

Figure 3.1. (a) Conformation of N-acetylneuraminic acid (Neuc5AC, left) and Nglycolylneuraminic acid (Neu5Gc, right) (b) The family of naturally occurring sialic acids.7
.
3.1.1 Detection of Sialic acids
The importance of sialic acids on cell surfaces makes development of methods for
identify and studying them, for possible applications in clinical research and diagnosis
attractive to chemists and biologists. Several successful methods developed rely on
metabolic labeling of cells using analogues of glycan precursors that carry bioorthogonal
reporters such as azides or alkynes, for ligation by fluorescent or biotin tags containing
complementary functional groups.9-11 The metabolic incorporation of the analogues
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containing bioorthogonal functional groups is nonetheless not trivial, and makes the
process inadaptable for clinical purposes.
A number of methods were therefore developed for direct detection of sialic acids
on cell surfaces. These include the use of boronic acid containing sensors that bind to diols
of sialic acids,12,13 lectins,14 or aptamers.15
Another efficient approach involves exploiting the intrinsic reactivity of sialic acids
to generate aldehydes on the surface of the cells.16 The glycerol side chain of sialic acids
react with sodium periodate at mild conditions to form aldehydes, which could
subsequently react with an amine to form a Schiff base. Hydrazine and hydroxylamines
tethered to biotins or fluorescent molecules have been ligated with glycoproteins,
glycolipids and glycopeptides containing sialic acid using this approach.17,18 Although this
method could detect other carbohydrates, under suitably mild conditions, periodates
selectively oxidize sialic acids to their C-7 aldehydes, while vicinal diols in the other
carbohydrates remain intact (Scheme 3.1).16,19,20
The absence of native aldehydes or ketones on cell surfaces makes the periodatepromoted ligation of amines to sialic acids on cell surfaces chemoselective. However, low
reactivity of the α-effect amines makes its applications in vivo almost impractical. To
circumvent that, aniline was used as a nucleophilic catalyst to catalyze the reaction of the
α-effect amines to the sialic acids via transamination.21-23 The introduction of aniline as a
catalyst was observed not only to increase the kinetics of the reaction, but allowed the
ligation to be carried out at neutral pH instead of the slightly acidic medium that only works
for the non-catalyzed reactions.
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Scheme 3.1. Covalent labeling of sialic acids on cell surface with α-effect amines. Mild periodate treatment selectively
oxidizes the terminal glycol of sialic acids to aldehyde for oxime or hydrazine ligation by aminoxy reagents or hydrazine
reagent respectively.

In light of the above discoveries, we envisioned that 1,8-diaminonapthalene (DAN)
could be assembled on a Quartz Crystal Microbalance (QCM) chip coated with a graphene
and successfully used to detect sialic acids in solution and cell surfaces.
3.1.1 Quartz crystal microbalance
Quartz crystal microbalances (QCM) are ultrasensitive devices that utilize converse
piezoelectric effect to determine the mass change from a change in frequency of a quartz
crystal resonator.24,25 They are capable of measuring masses down to 1 ng/cm2. The
relationship between the frequency of the quartz crystal and the change in mass was first
reported by Sauerbrey.26 He observed that when a voltage is applied to a quartz crystal, it
oscillates at a specific frequency. An increase in an elastic mass bound to the quartz surface
causes the crystal’s oscillation frequency to decrease, and vice versa. The relationship
between the change in the mass (∆m) and the corresponding change in the frequency (∆f)
was given by the Sauerbrey equation.

(∆f) = -2∆mf 2/A (µρq) 0.5 = - Cf ∆m

(1)

Where ∆f is the measured frequency decrease in Hz, f is the intrinsic crystal frequency and
∆m is the elastic mass in g. A is the electrode area cm2, ρq is the density of quartz in g/cm3,
µ is the shear modulus in dyn/cm2 and Cf is the integrated QCM sensitivity in Hz/ng. The
Sauerbrey equation is only valid for small elastic masses added to the crystal surface. When
the change in mass is greater than 2% of the crystal mass, the equation becomes invalid.
The QCM chip is a shear mode device consisting of a thin quartz disk with coated
electrodes. The electrodes can be made of a number of metals (e.g. gold, silver, platinum
etc), and are connected by wires for transmitting the oscillatory signals to a transducer. The
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quartz crystal plate must be cut to a specific orientation with respect to the crystal axes (i.e.
AT or BT) so that acoustic wave propagates perpendicular to the crystal axes. The AT cuts
(35o, 15') from the Z axis of the crystal are the most widely used.27,28 The sensitivity of the
QCM is inversely proportional to thickness of the crystal: the thinner the crystal, the higher
its resonance frequency and sensitivity. Quartz crystals are therefore polished to a hair-thin
disc that supports resonance of 1-30 MHz. The diameter of the crystal usually is in the
range of 0.3 – 0.5 inches. The temperature dependence of the AT cut is zero at room
temperature.28
To make the QCM sensitive and specific to a particular analyte, a recognition motif
is first adsorbed onto the electrode, followed by introduction of the analyte to the electrodemodified crystal chip. Binding of the analyte onto it recognition motif adsorbed on the
quartz chip causes a change in mass, resulting in a change the quartz vibration frequency.
This procedure has found utility in the detection and quantifying of a number of important
analytes, spanning volatile organic compounds, inorganic molecules, biomolecules, cells
and pathogens.29,30
3.2 RESULTS AND DISCUSION
2.2.0 Development of QCM sensors for sialic acid
The ability of graphene to assemble on QCM and subsequent adsorption of
aromatic compounds onto graphene surfaces via π-π stacking has been previously
reported.31,32 Since amines could react with sialic acids after treatment of the sialic acid
with sodium periodate, which converts the terminal diols of the sialic acid into an aldehyde,
we anticipated that, immobilizing 1,8-diaminonaphthalene (DAN) onto a QCM coated with
graphenes could serve as a sensitive and facile method for detection of sialic acids in
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solutions and on cell surfaces. Scheme 3.2 shows the proposed reaction scheme between
DAN and sialic acid pretreated with sodium periodate. To this end, graphene was
immobilized onto silver-coated QCM chips, followed by assembling of DAN on the
graphene surfaces (Figure 3.2). The extent of addition of new materials onto the surface of
the chip was determined by the change in the frequency of the QCM chip when the chip
was connected to a QCM transducer. When a mass was added a decrease in frequency was
observed.

Scheme 3.2. Reaction of 1,8-diaminonapthalene (DAN) with sialic acid pretreated with
sodium periodate.

Figure 3.3a shows the QCM responses for graphene adsorption, DAN assembly,
and subsequent binding of sialic acid pretreated with sodium periodate to the functionalized
QCM chip. The initial measurement of the QCM chip, which is about 9 MHz was taken
after thoroughly washing the chip with ethanol, followed by water and blow-drying with
nitrogen. A decrease in the QCM frequency was observed when the chip was later
introduced into a suspension of graphenes in ethyl acetate for an hour. To ensure that the
change in frequency is only due to the graphenes adsorbed onto the silver surface, the QCM
chip was introduced into the graphene solution vertically, and afterwards, washed
thoroughly with water and blow-dried with nitrogen to remove any non-binding graphenes
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on the QCM surface. This process was repeated for DAN, dissolved in 50% acetonitrile in
water, and resulted in further decrease in the frequency of the QCM chip. Subsequently,
the QCM chip functionalized with layers of graphene and DAN was used as a sensing
platform for sialic acids. As expected, binding of sialic acid, or any analyte resulted in a
further decrease in the frequency, whiles in the cases where no binding occurred, no
significant change in the QCM frequency was observed.
Contrary to previous reports that ligation of hydrazines and hydroxylamines to
aldehydes only occur, or are at optimum in acidic buffers. The binding of DAN to sialic
acid was equally significant at pH = 7.4, and also in deionized water, according to the
change in frequencies we observed for the same concentration of sialic acids in three
solutions (deionized water, sodium phosphate buffer, pH = 7.4 and sodium acetate buffer
pH = 4.6). We therefore chose pH 7.4 for all our subsequent sensing experiments. No
changes in frequency was observed when the experiment was repeated for sialic acids that
had not been pretreated with sodium periodate. To establish that this method is selective
for sensing sialic acids, the experiment was carried out on glucose, with or without
treatment with sodium periodate. No frequency change was observed in both treated and
untreated glucose as shown in (Figure 3.3 b)
When the binding of sialic acid (1 mg/mL) pretreated with sodium peridodate (0.1
M, 300 µM) to the modified QCM chip was measured with time, an increase in frequency
was observed with time for up to about 50 minutes after which no significant change in the
frequency was observed (Figure 3.4a). This was due to the fact that all the amines on the
QCM surface had reacted with the aldehydes in solution. We further prepared different
concentrations of the sialic acid, ranging from 1 mg/mL to 10-6 mg/mL and treated them
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with sodium periodate for sensing with our QCM chips modified with DAN. Sensitivity of
the QCM chips for sialic acid was observed down to 10 -5 mg/mL. No significant frequency
shift was observed for sialic acid concentrations below this concentration after introducing
the sensors into the solutions for up to 20 minutes. As anticipated, above this critical
sensing concentration, a decrease in frequency was observed with increasing concentration
of the sialic acid (Figure 3.4b).

(a)

AT cut quartz crystal (b)
Silver
electrode
Electrical
lead

To the circuit &
voltage supply

Figure 3.2. (a) Schematic of QCM chip showing one of its two same sides (b) Assembly
of DAN on graphene via µ-µ interaction. The graphene is first adsorb onto the silver
electrode on both sides of the QCM chip before the DAN assembly.
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Figure 3.3. Frequency shift in response to sequential binding of graphene, DAN and sialic
acid to QCM chip. (b) Frequency shift in response to sequential binding of graphene, DAN
and glucose. No frequency change was observed for binding of glucose to DAN.
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Figure 3.4 (a) Plot of frequency shift with time for binding of sialic acid (1mg/mL)
pretreated with sodium periodate (0.1 M, 300 µL) to QCM-DAN sensing platform. A
steady decrease in frequency with time up to 50 minutes observed after which there was
no significant change in the frequency. (b) Frequency shifts observed for introducing
QCM-DAN chips into different concentrations of sialic acid pretreated with sodium
periodate. The chips are immersed in the sialic acid solution for 20 minutes, rinsed with
deionized water, blow-dried with nitrogen and the frequency measured on a transducer.

Having established the effectiveness of our probe for sensing sialic acids, we moved
on to detect sialic acids on a sialo protein, fetuin from fetal bovine serum. Two different
samples of the proteins were prepared in a sodium phosphate buffer (0.5 mg/mL, pH 7.4).
One was treated with a neuraminidase and the other solution remained untreated.
Neuraminidase are sialic acid cleaving enzymes. When a sialoprotein is treated with
neuraminidase, the sialic acids on the proteins are expected to be cleaved from the protein.
Sodium periodate solutions (0.1 M, 300 µL) was later added to the two sialoprotein
solutions at 0 oC and the solutions kept at the same temperature for 30 minutes. The QCMmodified chips that was introduced into the untreated sialo protein for 30 minutes showed
an averaged frequency decrease of almost 270 Hz after three trials whiles the chips
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introduced into proteins treated with the enzyme had only about 50 Hz of frequency shift
(Figure 3.5). We surmise that there was more decrease in frequency for the untreated
sialoprotein because the sialic acids are attached to a higher molecular weight proteins,
whereas the treated sialoproteins had mostly free and low molecular weight sialic acid in
solution.

Figure 3.5 QCM response for fetunin from bovine serum after treatment with sodium
periodate. The fetunin solution without neuraminidase showed a higher frequency shift
than the one treated with neuraminidase.

3.2.1 Labeling of bone marrow stem cell sialic acids
We subsequently applied the method we have developed in detecting sialic acids
on bone marrow stem cells that have been incubated and allowed to divide over 21 days.
Stem cells are undifferentiated cells that have the ability divide, self-renew and
differentiate into other types of cells. The differentiation of stem cells is associated with
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antigens on the cell surface, which are made of glycoproteins or glycolipids. 33-35 The
terminal sugar residues of these glycoproteins or glycolipids are usually sialic acids and
thus can be detected using the method developed above. To this end, cells that were
incubated in a medium and allowed to divide were tested for the presence of sialic acids on
their surfaces at 0,7,14 and 21 days. Using the procedure reported earlier for detecting
sialic acids, the cells were subjected to mild periodate oxidation to selectively introduce
aldehyde to the terminal sialic acids and subsequently tested for their ability to bind to our
DAN-modified QCM chips. As shown in Fig. 3.5, no frequency shifts were observed at
day zero, but frequency shift were observed in the subsequent measurements, increasing
with the number of days of incubation. Also, the 40 k cells had higher frequency shifts that
the 20 k cells for each measurement. Control reactions for the stem cell not treated with
sodium periodate did not show any frequency shifts, indicating the binding was due to the
introduction of aldehydes on the cell surface.
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Figure 3.6 Frequency shifts in response to binding of cell surface sialic acid to QCM chips
modified with DAN for 20 k cells (black) and 40k (cells) red, at 0, 7, 14 and 21 days.
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3.3 CONCLUSION
A novel QCM-based method for detection of sialic acids in solutions and on cell
surfaces has been developed. The method involves selective oxidation of the glycerol side
chain of sialic acids to form an aldehyde and subsequent reaction with amines immobilized
on QCM surface. A successful reaction of the amine with the oxidized sialic acid causes a
decrease in the QCM’s resonance frequency. The magnitude of the frequency shift is
directly proportional to the mass of sialic acid that binds to the QCM surface. Unlike
previous amine-based sialic acid sensors developed, which are effective only at slightly
acid pH, the QCM-DAN sensor developed is effective at physiological pH and thus can be
easily adapted for live cell sialic acid sensing.
3.4 EXPERIMENTAL SECTION
3.4.0 Materials
Proteck C3100 2.4 GHz programmable Universal Counter Quartz crystal microbalance
was used for all measurements. Graphene dispersion in butyl acetate was purchased from
Graphene Supermarket. All other reagents were of commercial grade and used without
further purification. Stem cells were supplied by our group member, Panita
Maturavongsadit.
Preparation of QCM sensors
The QCM chip were extensively cleaned with ethanol and water before being introduced
into graphene solution (1 mg/mL) in ethyl acetate to allow for deposition of graphene onto
the surface of the QCM chip. The chip was subsequently rinsed with water to allow, nonbinding graphenes on the surface of the chip to be removed. After measuring the frequency
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of the graphene-modified chip, the chip was introduced into a solution of 1,8diaminonaphthalene (DAN) in acetonitrile and water (1:1), (0.5 mg/mL) for 30 minutes.
The frequency of the QCM chip is again measured after rinsing the chip with water to
remove non-binding DAN on the surface and blow-dried with nitrogen. Unless otherwise
stated, sialic acid solutions were prepared in sodium phosphate buffer, pH 7.4., and
experiments conducted in triplicates.
3.4.1 Measurement process
QCM measurement were carried out on a Protek C3100 2.4 GHz Programmable Universal
Counter. The QCM chip was an AT-cut quartz crystal coated with silver on each side with
a fundamental resonance frequency of 9 MHz. The principle of the QCM sensor is based
on changes in the oscillating frequency of the QCM chip upon an analyte binding onto the
silver-coated surface. For a small elastic object, there is a linear relationship between the
amount of mass adsorbed onto the crystal surface (usually in the 1 ng cm-2 range) and the
frequency shift of the crystal in air or vacuum according to the Sauerbrey equation.36,37
Δm = − CΔfn /n
Where Δm is the mass change, C is the instrument constant, n is the vibrational mode
number and Δfn is the resonant frequency change for mode n. The instrument reports Δfn
/n in Hz.
Cell isolation and culture
BMSCs were isolated from the bone marrow of young adult 160-180 g male SpragueDawley rats (Charles River Laboratories) as described in our previous reports.38,39 The
procedures were performed in accordance with the guidelines for animal experimentation
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by the Institutional Animal Care and Use Committee, School of Medicine, University of
South Carolina. The cells were passaged no more than seven times after isolation and
maintained in complete primary media (Dulbecco’s Modified Eagle’s Medium (DMEM)
supplemented with 10% fetal bovine serum (FBS)), kept at 37 °C in a CO2 incubator with
5% CO2 : 95% air. The medium was replaced every 3-4 days.
Osteogenic differentiation of BMSCs
BMSCs were harvested from 80% confluent culture flask using 0.25%
trypsin/EDTA for 5 min and counted and resuspended in complete primary media. A total
of 20 or 40 × 103 BMSCs were seeded per well. After 6 hours of an initial incubation,
primary media were replaced with osteogenic media consisting of DMEM supplemented
with 10% FBS, penicillin (100 U mL−1), streptomycin (100 μg mL−1), and amphotericin B
(250 ng mL−1), 10 × 10−3 M sodium β-glycerolphosphate, L –ascorbic acid 2-phosphate
(50 μg mL−1), and 10−8 M dexamethasone. Media were replenished every 3 days.
Detection of sialic acid on cell surfaces
After incubation, the cells were treated with sodium periodate (0.1 M, 300 µM) at
0 oC for 30 minutes to selectively introduce aldehyde to the terminal sialic acids This was
followed by introduction of DAN-modified QCM chips into the cell culture. The QCM
chips were removed after 30 minutes, washed with water, blow-dried with nitrogen and the
frequencies measured on the Protek C3100 2.4 GHz Programmable Universal Counter. The
measurement were conducted in triplicates with separate DAN-modified QCM chip for
each set of cells.

75

3.5 REFERENCES
(1)

Mahajan, V. S.; Pillai, S.: Sialic acids and autoimmune disease. Immunol. Rev.

2016, 269, 145-161.
(2)

Varki, A.: Sialic acids in human health and disease. Trends Mol. Med. 2008, 14,

351-360.
(3)

Kelm, S.; Schauer, R.: Sialic acids in molecular and cellular interactions. In

International Review of Cytology - a Survey of Cell Biology, Vol 175; Jeon, K. W., Ed.;
Elsevier Academic Press Inc: San Diego, 1997; Vol. 175; pp 137-240.
(4)

Wang, B.; Brand-Miller, J.: The role and potential of sialic acid in human nutrition.

Eur. J. Clin. Nutr. 2003, 57, 1351-1369.
(5)

Rabinovich, G. A.; van Kooyk, Y.; Cobb, B. A.: Glycobiology of immune

responses. Ann. N.Y. Acad. Sci. 2012, 1253, 1-15.
(6)

Dube, D. H.; Bertozzi, C. R.: Glycans in cancer and inflammation. Potential for

therapeutics and diagnostics. Nat. Rev. Drug Discovery 2005, 4, 477-488.
(7)

Schauer, R.: Sialic acids: fascinating sugars in higher animals and man. Zoology

2004, 107, 49-64.
(8)

Bi, S.; Baum, L. G.: Sialic acids in T cell development and function. Biochimica Et

Biophysica Acta-General Subjects 2009, 1790, 1599-1610.
(9)

Chang, P. V.; Chen, X.; Smyrniotis, C.; Xenakis, A.; Hu, T.; Bertozzi, C. R.; Wu,

P.: Metabolic Labeling of Sialic Acids in Living Animals with Alkynyl Sugars. Angew.
Chem. Int. Ed. 2009, 48, 4030-4033.
(10)

Laughlin, S. T.; Baskin, J. M.; Amacher, S. L.; Bertozzi, C. R.: In Vivo Imaging of

Membrane-Associated Glycans in Developing Zebrafish. Science 2008, 320, 664-667.

76

(11)

Hsu, T. L.; Hanson, S. R.; Kishikawa, K.; Wang, S. K.; Sawa, M.; Wong, C. H.:

Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells. Proc.
Natl. Acad. Sci. U.S.A. 2007, 104, 2614-2619.
(12)

Zhang, X.; Chen, B.; He, M.; Zhang, Y.; Peng, L.; Hu, B.: Boronic acid recognition

based-gold nanoparticle-labeling strategy for the assay of sialic acid expression on cancer
cell surface by inductively coupled plasma mass spectrometry. Analyst 2016, 141, 12861293.
(13)

Qian, R. C.; Ding, L.; Yan, L. W.; Ju, H. X.: Fluorescence imaging for in situ

detection

of

cell

surface

sialic

acid

by

competitive

binding

of

3-

(dansylamino)phenylboronic acid. Anal. Chim. Acta 2015, 894, 85-90.
(14)

Cao, H.; Yang, D.-P.; Ye, D.; Zhang, X.; Fang, X.; Zhang, S.; Liu, B.; Kong, J.:

Protein-inorganic hybrid nanoflowers as ultrasensitive electrochemical cytosensing
Interfaces for evaluation of cell surface sialic acid. Biosens. Bioelectron. 2015, 68, 329335.
(15)

Cho, S.; Lee, B.-R.; Cho, B.-K.; Kim, J.-H.; Kim, B.-G.: In vitro selection of sialic

acid specific RNA aptamer and its application to the rapid sensing of sialic acid modified
sugars. Biotechnol. Bioeng. 2013, 110, 905-913.
(16)

Kohler, J. J.: Aniline: A Catalyst for Sialic Acid Detection. ChemBioChem 2009,

10, 2147-2150.
(17)

Zhang, Y.; Yuan, J.; Song, J.; Wang, Z.; Huang, L.: An efficient method for

selectively imaging and quantifying in situ the expression of sialylated glycoproteins on
living cells. Glycobiology 2013, 23, 643-653.

77

(18)

Zeng, Y.; Ramya, T. N. C.; Dirksen, A.; Dawson, P. E.; Paulson, J. C.: High-

efficiency labeling of sialylated glycoproteins on living cells. Nat. Meth 2009, 6, 207-209.
(19)

Liao, T.-H.; Gallop, P. M.; Blumenfeld, O. O.: Modification of Sialyl Residues of

Sialoglycoprotein(s) of the Human Erythrocyte Surface. J. Biol. Chem. 1973, 248, 82478253.
(20)

Jourdian, G. W.; Dean, L.; Roseman, S.: The Sialic Acids: XI. A Periodate-

Resorcinol Method For The Quantitative Estimation Of Free Sialic Acids And Their
Glycosides. J. Biol. Chem. 1971, 246, 430-435.
(21)

Key, J. A.; Li, C.; Cairo, C. W.: Detection of Cellular Sialic Acid Content Using

Nitrobenzoxadiazole Carbonyl-Reactive Chromophores. Bioconjugate Chem. 2012, 23,
363-371.
(22)

Dirksen, A.; Hackeng, T. M.; Dawson, P. E.: Nucleophilic Catalysis of Oxime

Ligation. Angew. Chem. Int. Ed. 2006, 45, 7581-7584.
(23)

Zeng, Y.; Ramya, T. N. C.; Dirksen, A.; Dawson, P. E.; Paulson, J. C.: High-

efficiency labeling of sialylated glycoproteins on living cells. Nat. Methods 2009, 6, 207209.
(24)

King, W. H.: Piezoelectric Sorption Detector. Anal. Chem. 1964, 36, 1735-1739.

(25)

Vashist, S. K.; Vashist, P.: Recent Advances in Quartz Crystal Microbalance-Based

Sensors. J. Sensors 2011.
(26)

Sauerbrey, G. Z.: Use of quartz vibration for weighing thin films on a microbalance.

Phys. J. 1959, 155, 206-212.
(27)

Pavey, K. D.: Quartz crystal analytical sensors: the future of label-free, real-time

diagnostics? Expert Rev Mol Diagn 2002, 2, 173-86.

78

(28)

Janshoff, A.; Galla, H.-J.; Steinem, C.: Piezoelectric Mass-Sensing Devices as

Biosensors—An Alternative to Optical Biosensors? Angew. Chem. Int. Ed. 2000, 39, 40044032.
(29)

Juzeliunas, E.: Quartz crystal microgravimetry - fifty years of application and new

challenges. Chemija 2009, 20, 218-225.
(30)

Cheng, C. I.; Chang, Y. P.; Chu, Y. H.: Biomolecular interactions and tools for their

recognition: focus on the quartz crystal microbalance and its diverse surface chemistries
and applications. Chem. Soc. Rev. 2012, 41, 1947-1971.
(31)

Tang, D.; Li, Q.; Tang, J.; Su, B.; Chen, G.: An enzyme-free quartz crystal

microbalance biosensor for sensitive glucose detection in biological fluids based on
glucose/dextran displacement approach. Anal. Chim. Acta 2011, 686, 144-149.
(32)

Zhu, Y.; Hao, Y.; Adogla, E. A.; Yan, J.; Li, D.; Xu, K.; Wang, Q.; Honea, J.; Lin,

Q.: A graphene-based affinity nanosensor for detection of low-charge and low-molecularweight molecules. Nanoscale 2016, 8, 5815-5819.
(33)

Draper, J. S.; Pigott, C.; Thomson, J. A.; Andrews, P. W.: Surface antigens of

human embryonic stem cells: changes upon differentiation in culture. J. Anat. 2002, 200,
249-258.
(34)

Wright, A. J.; Andrews, P. W.: Surface marker antigens in the characterization of

human embryonic stem cells. Stem Cell Res. 2009, 3, 3-11.
(35)

Yu, R. K.; Suzuki, Y.; Yanagisawa, M.: Membrane Glycolipids in Stem Cells.

FEBS Lett. 2010, 584, 1694-1699.

79

(36)

Schneider, T. W.; Buttry, D. A.: Electrochemical quartz crystal microbalance

studies of adsorption and desorption of self-assembled monolayers of alkyl thiols on gold.
J. Am. Chem. Soc. 1993, 115, 12391-12397.
(37)

Ward, M. D.; Buttry, D. A.: In Situ Interfacial Mass Detection with Piezoelectric

Transducers. Science 1990, 249, 1000-1007.
(38)

Kaur, G.; Wang, C.; Sun, J.; Wang, Q.: The synergistic effects of multivalent ligand

display and nanotopography on osteogenic differentiation of rat bone marrow stem cells.
Biomaterials 2010, 31, 5813-24.
(39)

Luckanagul, J.; Lee, L. A.; Nguyen, Q. L.; Sitasuwan, P.; Yang, X.; Shazly, T.;

Wang, Q.: Porous alginate hydrogel functionalized with virus as three-dimensional
scaffolds for bone differentiation. Biomacromolecules 2012, 13, 3949-58.

80

CHAPTER 4
PYRENE-FUNCTIONALIZED BORONIC ACID SENSORS FOR
LABELING GLYCANS ON CELLS
4.1 INTRODUCTION
Glycans are one of the most abundant biomolecules found in cells.1. They are
involved in a wide array of biological processes, including cell-cell recognition, cell
differentiation, growth, immune response and modulation.2,3 Changes in glycan
expressions in cells have been linked to different cancers, and have been reported to
regulate different aspects of tumor progression, including proliferation, invasion and
metastasis.4-6 For example, overexpression of sialic acids have been linked to various
disease states such as cancers,4 cardiovascular diseases7 and neurological diseases.8
Moreover, overexpression of mannose sugar has also been reported in breast cancer
progression,9 and the overall level of fucose has been reported to be higher in ovarian and
pancreatic cancer cells compared to their corresponding normal cells.10
Existing methods for detecting and analyzing glycans include, mass
spectrometry,11-13 nuclear magnetic resonance14,15 and high performance liquid
chromatography.16 However, these methods involve first treating the cells with enzymes to
release the saccharides from the protein before analysis, either with or without
derivatization.11 Another approach is based on metabolic incorporation of a bioorthogonal
reporter into the cell by introducing synthetic analogues of natural monosaccharides
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bearing the biorthogonal reporters into the cell.17-21 The unnatural sugars are utilized in the
biosynthesis of glycans bearing the incorporated bioorthogonal reporters, which can be
subsequently conjugated with a various kinds of probes. The reaction between the
functionalized glycan and fluorescent probes allows visualization and monitoring of
glycans in living cells by means of fluorescence microscopy, or other analytical methods,
which is vital for elucidating protein glycosylation in the cell. Reporter groups such as
azides, alkynes alkenes and ketones are some of the functional groups that are suitable for
metabolic incorporation into the cell’s glycans and subsequent labeling with affinity
probes.20,22 However, bulky groups such as cyclooctynes could lead to perturbation of the
pathways, and consequently, a dysregulation of the cellular activities.
Another method relies on the recognition and affinity binding of the polyhydroxy
functional groups of the glycans in situ using lectins23 or boronic acids24. Lectins are class
of carbohydrate binding proteins. Different lectins exist that are specific for different
oligosaccharide sequences.25 However, this method suffers from limited tissue penetration
and toxicity. Boronic acids are synthetic recognition motif for glycans. They react rapidly
and reversibly with 1,2 and 1,3-diols of the glycans to form five- and six-membered ring
cyclic boronate esters respectively (Figure 4.1).26-28 The binding to glycans occurs at, or
near physiological pH, and both the boronic acids and their boronate ester products are
benign to cells, making this reaction suitable for biolabeling. The binding of boronic acid
to cell surface glycans also enhances transport of molecules attached to the boronic acid
into the cell. They are therefore employed in the delivery of polar molecules and drugs to
cells. In this work, we synthesized a number of pyrene- and naphthalimide-derivatized
boronic acids for glycan sensing. Pyrene is a versatile blue-fluorophore with high
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fluorescence quantum yields,29-31 and naphthalimide on the other hand are greenfluorescent emitting dyes.32 The spacers between pyrenes and boronic acids were varied to
obtain the optimum spacing needed for higher fluorescence intensity.
4.2 RESULTS AND DISCUSSION
Figure 4.1 shows different pyrene-derivatized boronic acids that were synthesized
for labeling glycans on cells. The boronic acid parts are the recognition motifs, whiles the
pyrenes are the fluorescent parts, for visualization and tracking of the molecules in cells.
The spacer length, and polarity of the sensors were varied to obtain the best design for
imaging cellular glycans. Pyrene boronic acids (8 µM) in 10% DMSO/H2O were prepared
and incubated with bone marrow stroma cells (BMSCs) in primary media at 37 oC for 30
minutes. The cells were subsequently washed three times with primary media, and fixed
with 4% paraformaldehyde for 15 minutes at room temperature. Finally, images of the
stained samples were collected using Olympus I×81 epi-flour mode under 10× and 20×
lens, exposure times 300 ms for DAPI and 700 ms for FITC channel. The cell imaging was
performed by our group member, Panita Maturavongsadit.
Different fluorescence intensities were observed for the different dyes, 4.1-4.7
under a fluorescence microscope (Figure 4.2). Dyes 4.1 and 4.2, which have ethyl and butyl
spacers respectively, linking a pyrene and 3-amidophenylboronic acid showed the highest
fluorescent labeling. When the amide in 4.2 was replaced by an amine to obtain 4.3, no
labeling was observed. The amphiphilic dyes 4.4 and 4.5 showed some labeling, but not as
effective as those of 4.1, and 4.2; whereas 4.6, which has a pentaethylene (PEG) linker
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Figure 4.1Structure of pyrene-derivatized boronic acid dyes for imaging cell surface glycans.
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Figure 4.2 Fluorescence images of BMSCs labeled with different pyrene-derivatized boronic acids (4.1-4.7) and pyrene (4.8).
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Figure 4.3.Fluorescence images of BMSCs labeled with dyes 4.1,4 2 and 4.8 and the corresponding fluorescent intensities.

separating the pyrene and the pyridinium boronic acid did not show any staining. However,
pyrene (8), which was not functionalized with boronic acid showed staining comparable to
4.1 and 4.2 (Figure 4.3). We thus concluded that pyrene-boronic acids with short alkyl
group separating them and linked by amide groups were more suitable for labeling the
glycans than those with polyethylene linkers and the amphiphiles. Internalization of the
dyes was also observed, which is consistent with the boronate ester-aided transport of
molecules across the cell membrane. However, pyrene (8), which has no boronic acid
attached was also internalized; thus the hydrophobicity pyrene moiety could also have
contributed to the internalization of the dyes.
To further establish the mechanism of the labeling and the internalization of the
dyes, two naphthalimide boronic acid dyes 4.9 and 4.10 were synthesized. After incubating
the dyes with BMSCs and collecting the images of the stained samples, we observed that
both dyes showed labeling and internalization, but the fluorescent intensity of 4.10 was
higher than that of the amphiphilic dye 4.9. (Figure 4.4).
4.3 CONCLUSION
Pyrene- and naphthalimide-derivatized boronic acid dyes were synthesized for
labeling cell surface glycans. The pyrenes, separated by alkyl chains and linked to the
boronic acids by amide bonds showed the highest fluorescent intensity. The amphiphilic
dyes showed lower fluorescence intensity than the hydrophobic dyes. After the surface
binding, via the reaction of the boronic motifs with the diols to form boronate esters, the
dyes entered the cytoplasm. This is evident by the labeling of the cytoplasm by the dye.
However, the incubation of the cells with a pyrene without boronic acid attached showed
the hydrophobicity of the pyrene might have also contributed significantly to the
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permeating of the dyes through the cell membrane to label the cytoplasm. We therefore
concluded that the pyrenes-derivatized boronic acid were not suitable for selectively
labeling glycans on cells. A suitable dye that is less hydrophobic, is therefore required to
carry the boronic acid motif for the selective labeling of cellular glycans.

Figure 4.4 Fluorescence images of BMSCs labeled with naphthalimide-derivatized boronic
acid dyes 4.9 and 4.10.
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4.4 EXPERIMENTAL SECTION
General. Unless otherwise specified all reagents and solvents were of commercial grade.
NMR spectra were recorded on Bruker 300 or 400 instruments. Flash column
chromatography was performed with silica gel (32-63 μm). High resolution mass
spectrometry (HRMS) was obtained using a magnetic sector mass spectrometer.

(3-(2-Pyrene-1-yl)acetamido)phenyl)boronic acid (4.1). Pyrene-1-acetic acid (50.0 mg,
0.19 mmol) in DMF (5 mL) was added EDCI (53.0 mg, 0.34 mmol) and DMAP (2.0 mg,
0.0017 mmol) at room temperature and stirred for 10 minutes, followed by addition of 3aminophenylboronic acid.monohydrate (31.0 mg, 0.20 mmol). The mixture was further
stirred at room temperature for 18 h. After the reaction was completed, the mixture was
diluted with ethyl acetate (20 mL) and washed with 1 N HCl and water. The organic layer
was dried over anhydrous sodium sulfate and concentrated in vacuo to obtain a light yellow
solid (60.0 mg, 81%). 1H NMR (400 MHz, DMSO) δ 10.41–10.39 (br s, 1H), 8.39 (t, J =
23.1 Hz, 1H), 8.30 – 8.19 (m, 4H), 8.17 – 8.00 (m, 7H), 7.89 (d, J = 15.5 Hz, 1H), 7.70 (d,
J = 8.1 Hz, 1H), 7.46 (d, J = 7.2 Hz, 1H), 7.26 (t, J = 7.7 Hz, 1H), 4.42 (s, 2H). 13C NMR
(101 MHz, DMSO) δ 169.67, 138.70, 131.24, 130.99, 130.76, 130.31, 129.69, 129.51,
129.22, 128.34, 127.89, 127.86, 127.43, 126.77, 125.75, 125.68, 125.50, 125.30, 124.55,
124.38, 124.32, 121.85, 41.30. HRMS (ESI): m/z (M-H) calcd for C24H18BNO3: 377.1338;
Found: 377.1347
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(3-(4-(Pyren-1-yl)butanamido)phenyl)boronic acid (4.2). Pyrene-1-butyric acid (100.0
mg, 0.34 mmol) in DMF (5 mL) was added EDCI (105.0 mg, 0.68 mmol) and DMAP (4.0
mg, 0.0034 mmol) at room temperature and stirred for 10 minutes, followed by addition of
3-aminophenylboronic acid.monohydrate (47.4 mg, 0.34 mmol). The mixture was further
stirred at room temperature for 18 h. The mixture was diluted with ethyl acetate and washed
with 1 N HCl (20 mL) and water (2 x 20 mL). The organic layer was dried over anhydrous
sodium sulfate and concentrated in vacuo to obtain a yellow solid (123.0 mg, 89%). 1H
NMR (400 MHz, DMSO) δ 9.93 (s, 1H), 8.35 (t, J = 10.0 Hz, 1H), 8.24 (dd, J = 7.6, 2.7
Hz, 2H), 8.19 (dd, J = 8.4, 6.8 Hz, 2H), 8.09 (d, J = 1.9 Hz, 1H), 8.03 (t, J = 7.6 Hz, 1H),
7.92 (t, J = 8.2 Hz, 1H), 7.87 (s, 1H), 7.71 (d, J = 8.0 Hz, 1H), 7.48 (d, J = 7.3 Hz, 1H),
3.43–3.29 (m, 2H), 2.47 (t, J = 7.2 Hz, 1H), 2.10 (dd, J = 14.7, 7.2 Hz, 2H). 13C NMR (101
MHz, DMSO) δ 171.77, 138.73, 136.88, 131.30, 130.83, 129.77, 129.50, 128.58, 128.28,
128.02, 127.90, 127.74, 126.99, 126.65, 125.77, 125.43, 125.28, 124.67, 124.56, 123.87,
121.97, 36.39, 32.63, 27.86. HRMS (ESI-H): m/z (M-H) calcd for C26H22BNO3: 405.1649;
found: 405.1651.
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Pyrene-1-butanaldehyde. To a solution of pyrenbutanol (274.0 mg, 1.0 mmol) in CH2Cl2
(4 mL) and DMSO (830 µL) was added Et3N (572 µL, 4.0 mmol) followed by addition of
SO3.pyridine (326.0 mg, 2.06 mmol) in 3 portions over 20 minutes. The mixture was stirred
for another 2 hours, diluted with ethyl acetate (10 mL) and washed with 1 N HCl and water.
The organic layer was concentrated in vacuo to afford a white solid, which was further
washed with diethyl ether to obtain pyrenebutanaldehyde (220.0 mg, 80%). 1H NMR (300
MHz, CDCl3) δ 9.82 (t, J = 1.4 Hz 1H), 8.30 (d, J = 9.3 Hz, 1H), 8.23-8.10 (m, 4H), 8.09
– 7.94 (m 3H), 7.86 (d, J = 7.8 Hz, 1H), 3.45 –3.34 (t, J = 7.5 Hz, 2H), 2.62-2.56 (m 2H),
2.33–2.13 (m, 2H).
4.3. To a solution of pyrene-1-butanaldehdye (214.0 mg, 0.78 mmol) in THF (10 mL) was
added a drop of acetic acid and 3-aminophenylboronic acid.monohydrate (120 mg, 0.78
mmol). After stirring for 5 minutes, NaBH(OAc)3 (330.0 mg, 1.57 mmol) was added. The
mixture was left to stir at room temperature overnight (18 h). The mixture was diluted with
ethyl acetate and washed with sodium bicarbonate. The organic layer wad dried over
anhydrous sodium sulfate, concentrated and dried in vacuo to obtain a white solid (280.0
mg, 91%). 1H NMR (400 MHz, DMSO) δ 8.36 (d, J = 9.3 Hz, 1H), 8.30-8.18 (m, 5H),
8.17–8.00 (m, 5H), 7.96 (d, J = 7.8 Hz, 1H), 7.90–7.74 (m, 1H), 7.69 (s, 2H), 7.50–7.25
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(m, 2H), 1.88 (d, J = 29.5 Hz, 4H). * 4 Protons under DMSO water peak. 13C NMR (101
MHz, DMSO) δ 136.97, 131.36, 130.89, 129.76, 129.15, 128.56, 127.96, 127.91, 127.71,
127.00, 126.62, 125.39, 125.26, 124.70, 124.61, 123.98, 32.59, 28.93. HRMS (ESI): m/z
(M+H) calcd for C24H25NO2: 394.2007; found: 394.2009.

4-(pyrene-1yl)-butyl methanesulfonate (4.4a). To pyrne-1-butanol (300.0 mg, 1.05 mL)
in CH2Cl2 (10 mL) was added Mscl (89 µL, 1.15 mmol) and TEA (417 µL, 3.0 mmol). The
mixture was stirred at room temperature overnight (18 h) and partitioned between 1 N HCl
and CH2Cl2. The organic layer was washed with water, dried over anhydrous sodium
sulfate, concentrated and dried in vacuo to obtain a light yellow liquid (360 mg, quant) as
the intermediate.1H NMR (300 MHz, CDCl3) δ 8.27 (d, J = 9.3 Hz, 1H), 8.22–8.09 (m,
4H), 8.07–7.97 (m, 3H), 7.87 (d, J = 7.8 Hz, 1H), 4.26 (t, J = 6.3 Hz, , 2H), 3.41 (t, J = 7.3
Hz, 2H), 2.96 (s, 3H), 2.51 (s, 3H), 2.14–1.81 (m, 4H).
4.4. The intermediate, 4-(pyrene-1yl)-butyl methanesulfonate (180.0 mg, 0.48 mmol) was
dissolved in DMF (1 mL) and 3-pyridyl boronic acid was added. The mixture was heated
to 100 oC for 36 h. Diethyl ether (10 mL x 2) was added to the reaction mixture and the
solvent decanted. An oily residue formed was dried in vacuo to obtain a brown solid (120
mg, 52%). 1H NMR (300 MHz, MeOD) δ 8.86 (d, J = 6.6 Hz, 2H), 8.12–7.84 (m, 5H),
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7.82-7.43(m, 6H), 4.72–4.40 (m, 1H), 3.45–3.28 (m, 2H), 2.25–2.00 (m, 1H), 2.02-1.98
(m, 1H). 13C NMR (75 MHz, MeOD) δ 145.25, 135.51, 131.37, 130.82, 130.01, 128.38,
127.94, 127.15, 127.12, 127.09, 126.42, 125.72, 124.69, 124.57, 124.51, 122.85, 61.48,
32.08, 30.77, 27.75. HRMS (ESI): m/z calcd for: 379.1853; found: 379.1852.

4.5a. Pyrene-1-butyric acid (500.0 mg, 1.7 mmol) in ethyl acetate (20 mL) was added 50%
propylphosphonic anhydride in ethyl acetate (1.07 mL, 3.6 mmol), dimethylaminoethanol
(465 µL, 4.5 mmol) and trimethylamine (614 µL, 4.5 mmol) and stirred at room
temperature for 1 h. The mixture was diluted with ethyl acetate and washed with saturated
sodium bicarbonate and water. The organic layer was dried over anhydrous sodium sulfate
and concentrated in vacuo to obtain compound 4.5a, as a dark oil (550.0 mg, 90%). 1H
NMR (400 MHz, CDCl3) δ 8.29 (d, J = 9.2 Hz, 1H), 8.17 (dd, J = 7.2, 4.1 Hz, 2H), 8.12
(dd, J = 8.5, 3.3 Hz, 2H), 8.06–7.95 (m, 3H), 7.85 (d, J = 13.6, 1H), 4.30 (t, J = 5.3 Hz,
2H), 4.28–4.09 (m, 1H), 3.41 (t, J = 7.6 Hz, 2H), 2.76 (t, J = 5.3 Hz, 2H), 2.52 (t, J = 7.2
Hz, 2H), 2.44 (s, 6H), 2.27–2.12 (m, 2H). 13C NMR (101 MHz, CDCl3) δ 211.35, 172.98,
135.65, 131.41, 130.89, 130.01, 128.77, 127.50, 126.79, 125.94, 125.01, 123.31, 67.91,
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59.54, 44.16, 38.75, 33.52, 32.52, 26.36. HRMS (ESI): m/z (M+H) calcd for C24H25NO2:
360.1964; found: 360.1965.
4.5. To 4.5a (440 mg, 1.2 mmol) in a mixture of THF (10 mL) and DMF (1 mL) was added
(3-bromomethyl)phenylboronic acid (262.0 mg, 1.2 mmol) and stirred at room temperature
for 5 h. The THF was removed and diethyl ether (20 mL) was added to precipitate the
product. The precipitate was filtered and dried in vacuo to obtain a light yellow solid as the
desired product (415.1 mg, 70%). 1H NMR (300 MHz, MeOD) δ 8.34 (d, J = 9.3 Hz, 1H),
8.18 (d, J = 7.8 Hz, 2H), 8.12 (s, 1H), 8.09 (d, J = 2.4 Hz, 1H), 8.05–8.01 (m, 2H), 7.98 (d,
J = 7.8 Hz, 1H), 7.86 (t, J = 9.9 Hz, 2H), 4.54–4.41 (m, 4H), 3.57 (dd, J = 5.8, 3.8 Hz, 2H),
3.45–3.35 (m, 2H), 2.98 (s, 6H), 2.54 (t, J = 7.2 Hz, 2H), 2.31–2.07 (m, 2H).

13

C NMR

(101 MHz, MeOD) δ 172.70, 135.59, 131.40, 130.00, 128.58, 127.14, 126.40, 125.67,
124.67, 124.54, 123.02, 68.98, 62.36, 57.08, 49.43, 32.84, 32.03, 25.99. HRMS (ESI): m/z
(M+) calcd for C31H33BNO4+: 493.2539; found: 493.2547.
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4.6a. To pyrene-1-butyric acid (1.4 g, 5.0 mmol) in DMF (20 mL) was added EDCI (1.05
g, 5.5 mmol) and DMAP (0.1 g, 0.5 mmol) at 0 oC. The mixture was stirred at room
temperature for 10 minutes followed by addition of pentaethylene glycol (2.1 mL, 10.5
mmol). The mixture was further stirred at room temperature for 18 h. The crude was diluted
with ethyl acetate and washed with 1N HCl and water. The organic layer was concentrated,
dried in vacuo and purified on silica gel column using CH2Cl2:CH3OH (10:0.1–10:1)
gradient to obtain a yellow oil. (1.3 g, 51%). 1H NMR (400 MHz, CDCl3) δ 8.26-8.20 (m,
1H), 8.12–8.01 (m, 4H), 7.96–7.87 (m, 3H), 7.83–7.76 (m, 1H), 4.21-4.11 (m, 2H), 3.65–
3.60 (m, 4H), 3.59–3.43 (m, 14H), 3.31 (t, J = 7.6 Hz, 2H), 2.51 (s, 3H), 2.41 (t, J = 7.6
Hz, 2H), 2.22-2.02 (m, 2H). 13C NMR (101 MHz, CDCl3) δ 173.49, 135.77, 131.42,
130.91, 129.98, 128.76, 127.50, 127.41, 126.72, 125.86, 125.10, 125.00, 124.92, 124.83,
124.78, 123.37, 72.51, 70.56, 70.51, 70.28, 69.17, 63.51, 61.74, 33.81, 32.76, 26.80.
4.6b. To compound 4.6a (800.0 mg, 1.6 mmol) in CH2Cl2 (20 mL) was added MsCl (198.4
mg, 1.72 mmol) and TEA (445 µL, 3.2 mmol). The mixture was stirred at room temperature
for 2 h. The crude was washed with 1 N HCl and water. The organic layer was dried over
anhydrous sodium sulfate, concentrated and purified on silica gel using CH2Cl2 to obtain
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compound 4.6b as a dark oil (795 mg, 86%). 1H NMR (300 MHz, CDCl3) δ 8.24 (d, J =
9.3 Hz, 1H), 8.13–8.01 (m, 4H), 7.97–7.95 (m, 2H), 7.92 (t, J = 7.6 Hz, 1H), 7.80 (d, J =
7.8 Hz, 1H), 4.23–4.14 (m, 2H), 3.68–3.59 (m, 4H), 3.58–3.45 (m, 12H), 3.33 (t, J = 7.8
Hz, 2H), 2.97 (s, 3H), 2.43 (t, J = 7.3 Hz, 2H), 2.22-2.02 (m, 2H), 1.57–1.50 (m, 2H).13C
NMR (101 MHz, CDCl3) δ 127.50, 127.41, 126.73, 125.87, 124.93, 124.79, 123.37, 70.59,
70.56, 70.47, 69.25, 69.18, 68.98, 63.50, 37.72, 33.82, 32.75, 26.80. HRMS (ESI): m/z
(M+) calcd for C31H38O9S: 587.2315; found: 587.2333
4.6. A mixture of compound 4.6b (680.0 mg, 1.16 mmol) and 3-pyridyl boronic acid (141
mg, 1.16 mmol in DMF (5 mL) was heated to 60 oC and stirred for 18 h. The mixture was
cooled to room temperature and diethyl ether was added. A precipitate formed was filtered
and dried in vacuo to obtain 4.6 as a yellow solid (310 mg, 43%) 1H NMR (300 MHz,
MeOD) δ 8.86 (d, J = 6.6 Hz, 1H), 8.12–7.84 (m, 5H), 7.82-7.43(m, 6H) δ 4.67–4.48 (m,
2H), 4.27–4.08 (m, 2H), 3.87–3.72 (m, 2H), 3.72–3.64 (m, 2H), 3.62-3.48 (m, 4H),3.493.34 (m, 10H) 2.50 (t, J = 7.1 Hz, 2H), 2.27–1.96 (m, 2H). 13C NMR (75 MHz, MeOD) δ
175.89, 136.31, 132.03, 131.17, 130.52, 129.22, 127.26, 127.04, 126.37, 125.70, 125.15,
124.64, 124.50, 123.12, 70.02, 69.90, 68.72, 63.17, 33.25, 32.16, 26.76. HRMS (ESI): m/z
(M+) calcd for C25H23BNO2: 613.2916; found: 613.2972.
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4.7a. To pyrene-1-butyric acid (576.0 mg, 2.0 mmol) in DMF (10 mL) was added EDCI
(930 mg, 6.0 mmol) and DMAP (24.0 mg, 0.2 mmol) at 0 oC. The mixture was stirred at
room temperature for 5 minutes followed by addition of triethylene glycol (818.0 mg, 6.0
mmol). The reaction was further stirred at room temperature overnight. The mixture was
diluted with ethyl acetate and washed with 1 N HCL and water. The organic layer was
dried over anhydrous sodium sulfate, concentrated in vacuo, and purified on silica gel
column using CH2Cl2: MeOH (1.0:0 to 1.0-0.05) gradient as eluent to obtain 4.7a as a light
yellow liquid (450.0 mg, 53%). 1H NMR (400 MHz, CDCl3) δ 8.26-8.20 (m, 1H), 8.12–
8.01 (m, 4H), 7.96–7.87 (m, 3H),7.78 (d, J = 7.8 1H), 3.64–3.59 (m, 2H), 3.57–3.44 (m,
12H), 3.35–3.25 (m, 2H), 2.88–2.72 (m, 2H), 2.40 (dt, J = 19.7, 8.6 Hz, 2H), 2.20–1.97
(m, 2H). 13C NMR (75 MHz, MeOD) δ 173.77, 166.87, 135.75, 131.37, 130.86, 129.91,
129.03, 128.49, 127.32, 127.12, 126.96, 126.28, 125.56, 124.76, 124.67, 124.53, 124.41,
123.02, 70.16, 70.08, 68.72, 68.69, 63.74, 63.21, 33.17, 32.11, 26.61.
4.7. To 3-boronobenzoic acid (100.0 mg, 0.60 mmol) in DMF (1 mL) was added EDCI
(186 mg, 1.2 mmol) and DMAP (12.2 mg, 0.1 mmol). The mixture was stirred at room
temperature for 30 minutes followed by addition of pyrenebutyltriethyleneglycol ester
4.7a. (126. 0mg, 0.3 mmol) the reaction was further stirred at room temperature for 48 h.
The mixture was diluted with ethyl acetate and washed with 1 N HCl and water. The
organic layer was dried over anhydrous sodium sulfate and concentrated in vacuo. The
crude was purified on silica gel column using hexane:ethyl acetate (1:3) to obtain a thick
brown liquid (45 mg,) 1H NMR (300 MHz, MeOD) δ 8.45-8.32 (m, 1H), 8.26-8.19 (m,
1H), 8.14-8.00 (m, 4H), 7.99–7.85 (m, 4H), 7.80 (d, J = 7.8 1H), 7.50 – 7.24 (m, 2H), 4.634.50 (m, 2H), 4.39–4.25 (m, 2H), 4.21–4.07 (m, 2H), 3.71–3.56 (m, 4H), 3.54-3.51 (m,
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4H), 3.48-3.21 (m, 1H), 2.39 (t, J = 7.2 Hz, 2H), 2.22–1.86 (m, 2H). 13C NMR (75 MHz,
MeOD) δ 173.77, 166.87, 135.75, 131.37, 130.86, 129.91, 129.03, 128.49, 127.32, 127.12,
126.96, 126.28, 125.56, 124.76, 124.67, 124.53, 124.41, 123.02, 70.16, 70.08, 68.72,
68.69, 63.74, 63.21, 33.17, 32.11, 26.61. HRMS (ESI): m/z (M+Na) calcd for C33H33BO8:
590.2202; found: 590.2197.

49a. To 8-bromonapthalimide anhydride (600.0 mg, 2.2 mmol) in EtOH (5 mL) was added
2-(2-aminoethoxy) ethan-1-ol) (1.0g, 9.5 mmol). The mixture was stirred at room
temperature for 5 h. A precipitate formed was filtered and dried to obtain a white solid
(660.5 mg, 83.0 mmol) 1H NMR (300 MHz, CDCl3) δ 8.68 (d, J = 7.1 Hz, 1H), 8.60 (d, J
= 8.4 Hz, 1H), 8.44 (d, J = 7.8 Hz, 1H), 8.06 (d, J = 7.8 Hz, 1H), 7.87 (t, J = 7.9 Hz, 1H),
4.45 (t, J = 5.3 Hz, 2H), 3.87 (t, J = 5.3 Hz, 2H), 3.76-3.21 (m, 4H). 13C NMR (101 MHz,
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CDCl3) δ 163.97, 133.52, 132.31, 131.48, 131.18, 129.57, 128.15, 124.30, 122.38, 72.25,
68.37, 61.86, 39.67. HRMS (ESI): m/z (M+H) calcd for C16H14BrNO4: 364.0180; found:
364.0179.

4.9b. To 4.9a (330.2 mg, 0.9 mmol) was added pyrrolidine (1 mL) and the mixture refluxed
for 4 h. The mixture was cooled to room temperature, diluted with ethyl acetate and washed
with 1 N HCL, concentrated sodium bicarbonate and brine The organic layer was
concentrated and dried in vacuo to obtain an orange solid (290 mg, 90%). 1H NMR (300
MHz, CDCl3) δ 8.64–8.54 (m, 1H), 8.42 (d, J = 8.6 Hz, 1H), 7.59–7.49 (m, 1H), 6.83 (d, J
= 8.7 Hz, 1H), 4.44 (t, J = 5.4 Hz, 2H), 3.85 (t, J = 5.4 Hz, 2H), 3.80 (t, J = 6.3 Hz, 4H),
3.73–3.64 (m, 4H), 2.16-2.06 (m, 4H).

13

C NMR (101 Mhz, CDCl3) δ 164.32, 133.58,

132.02, 131.40, 123.37, 122.69, 122.41, 109.12, 72.23, 68.67, 61.89, 53.49, 39.29, 26.03.
HRMS (ESI): m/z (M+H) calcd for: C20H22N2O4 355.1649; found: 355.1652.
4.9. To 3.27 (88.0 mg, 0.25 mmol) in DMF (2 ML) was added 90% NaH (26.0 mg, 1.0
mmol) and stirred at room temperature for 10 minutes. 3-benzylbromide-boronic acid (44.0
mg, 0.25 mmol) was added and the mixture left to stir at room temperature of 8 h. The
mixture was diluted with ethyl aceate and washed with brine and water. The organic layer
was dried over anhydrous sodium sulfate and purified on silica gel column using
hexane:ethyl acetate (1:0 – 1:1) to obtain an orange liquid (40 mg 32%) 1H NMR (400
MHz, MeOD) δ 8.61 (d, J = 8.5 Hz, 1H), 8.43-8.33 (m, 1H), 8.19 (d, 8.8 Hz, 1H), 7.59 (s,
1H), 7.54–7.42 (m, 2H), 7.25-7.12 (m, 2H), 6.88-6.59 (m, 2H), 4.66-4.54 (m, 4H),4.444.34 (m, 2H), 3.87–3.67 (m, 4H), 3.67–3.43 (m, 4H), 2.08 (t, J = 13.8 Hz, 4H). 13C NMR
(101 MHz, MeOD) δ 165.28, 164.45, 164.19, 152.91, 133.21, 132.74, 130.75, 130.69,
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122.58, 122.06, 121.43, 108.20, 72.05, 70.18, 69.18, 67.79, 67.64, 60.87, 52.89, 52.85,
38.78, 38.66, 25.60. HRMS (ESI): m/z (M+) calcd for C27H29BN2O6: 488.2232; Found:
488.228.

4.10. Compound 4.9b (162.0 mg, 0.45 mmol) in CH2Cl2 was added MsCl (84 µL, 1.0
mmol) and TEA (100 µL). The mixture was stirred at room temperature overnight (22 h).
The mixture was afterwards diluted with ethyl acetate and washed with 1 N HCl,
concentrated sodium bicarbonate and brine. The organic layer was dried over sodium
sulfate anhydrous and concentrate in vacuo. The crude was redissolved in DMF (1 mL)
and 3-pyridine boronic acid (55.0 mg, 0.45 mmol) was added and stirred at 90 oC for 36
h. The reaction mixture was cooled to room temperature and diethyl ether was added to the
reaction mixture. A black oily residue was formed at the bottom. The diethyl ether was
decanted and the oily residue further washed twice with diethyl ether and dried in vacuo to
obtain a yellow solid (145 mg, 58%) as 4.10.1H NMR (400 MHz, MeOD) δ 8.92–8.78 (m,
2H), 8.70 – 8.57 (m, 1H), 8.54 (d, J = 8.0 Hz, 1H), 8.40–8.24 (m, 2H), 8.15–8.01 (m, 1H),
7.87 (t, J = 6.8 Hz, 1H), 7.48 (dd, J = 15.7, 7.8 Hz, 1H), 4.34 –4.14 (m, 2H), 4.07 –3.92
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(m, 2H), 3.87–3.70 (m, 6H), 3.68-3.55 (m, 2H) 2.52 (s, 3H), 2.19-2.08 (m, 4H). 13C NMR
(101 MHz, MeOD) δ 164.69, 152.78, 145.31, 145.09, 133.28, 132.79, 130.78, 127.41,
122.57, 121.93, 121.18, 108.17, 72.07, 68.12, 67.96, 67.78, 61.35, 60.88, 52.94, 52.88,
38.36, 38.12, 34.04, 25.63. HRMS(ESI): m/z Calcd For C25H27BN3O5: 459.2075; Found:
459.2075

101

4.5 REFERENCES
(1)

Tian, Y.; Zhou, Y.; Elliott, S.; Aebersold, R.; Zhang, H.: Solid-phase extraction of

N-linked glycopeptides. Nat. Protocols 2007, 2, 334-339.
(2)

Marth, J. D.; Grewal, P. K.: Mammalian glycosylation in immunity. Nat. Rev.

Immunol. 2008, 8, 874-887.
(3)

Donin, N.; Jurianz, K.; Ziporen, L.; Schultz, S.; Kirschfink, M.; Fishelson, Z.:

Complement resistance of human carcinoma cells depends on membrane regulatory
proteins, protein kinases and sialic acid. Clin. Exp. Immunol. 2003, 131, 254-263.
(4)

Hakomori, S.: Aberrant glycosylation in cancer cell-membranes as focused on

glycolipids - overview and perspectives. Cancer Res. 1985, 45, 2405-2414.
(5)

Kim, Y. J.; Varki, A.: Perspectives on the significance of altered glycosylation of

glycoproteins in cancer. Glycoconj. J. 1997, 14, 569-576.
(6)

Dube, D. H.; Bertozzi, C. R.: Glycans in cancer and inflammation. Potential for

therapeutics and diagnostics. Nat. Rev. Drug Discov. 2005, 4, 477-488.
(7)

Lindberg, G.; Eklund, G. A.; Gullberg, B.; Råstam, L.: Serum sialic acid

concentration and cardiovascular mortality. Br. Med. J. 1991, 302, 143-146.
(8)

Varki, A.: Sialic acids in human health and disease. Trends Mol. Med. 2008, 14,

351-360.
(9)

de Leoz, M. L. A.; Young, L. J. T.; An, H. J.; Kronewitter, S. R.; Kim, J. H.;

Miyamoto, S.; Borowsky, A. D.; Chew, H. K.; Lebrilla, C. B.: High-Mannose Glycans are
Elevated during Breast Cancer Progression. Mol. Cell. Proteomics 2011, 10.
(10)

Ang, I. L.; Poon, T. C. W.; Lai, P. B. S.; Chan, A. T. C.; Ngai, S.-M.; Hui, A. Y.;

Johnson, P. J.; Sung, J. J. Y.: Study of Serum Haptoglobin and Its Glycoforms in the

102

Diagnosis of Hepatocellular Carcinoma: A Glycoproteomic Approach. J. Proteome Res.
2006, 5, 2691-2700.
(11)

Rudd, P. M.; Dwek, R. A.: Rapid, sensitive sequencing of oligosaccharides from

glycoproteins. Curr. Opin. Biotechnol. 1997, 8, 488-497.
(12)

Shriver, Z.; Raguram, S.; Sasisekharan, R.: Glycomics: a pathway to a class of new

and improved therapeutics. Nat. Rev. Drug Discov. 2004, 3, 863-873.
(13)

Harvey, D. J.: Proteomic analysis of glycosylation: structural determination of N-

and O-linked glycans by mass spectrometry. Expert Rev. Proteomics 2005, 2, 87-101.
(14)

Frullano, L.; Rohovec, J.; Aime, S.; Maschmeyer, T.; Prata, M. I.; de Lima, J. J. P.;

Geraldes, C. F. G. C.; Peters, J. A.: Towards Targeted MRI: New MRI Contrast Agents for
Sialic Acid Detection. Chem. Euro. J. 2004, 10, 5205-5217.
(15)

Neves, A. A.; Wainman, Y. A.; Wright, A.; Kettunen, M. I.; Rodrigues, T. B.;

McGuire, S.; Hu, D.-E.; Bulat, F.; Geninatti Crich, S.; Stöckmann, H.; Leeper, F. J.;
Brindle, K. M.: Imaging Glycosylation In Vivo by Metabolic Labeling and Magnetic
Resonance Imaging. Angew. Chem. Int. Ed. 2016, 55, 1286-1290.
(16)

Mun, J.-Y.; Lee, K. J.; Seo, H.; Sung, M.-S.; Cho, Y. S.; Lee, S.-G.; Kwon, O.; Oh,

D.-B.: Efficient Adhesion-Based Plasma Membrane Isolation for Cell Surface N-Glycan
Analysis. Anal. Chem. 2013, 85, 7462-7470.
(17)

Xie, R.; Hong, S.; Chen, X.: Cell-selective metabolic labeling of biomolecules with

bioorthogonal functionalities. Curr. Opin. Chem. Biol. 2013, 17, 747-752.
(18)

Laughlin, S. T.; Baskin, J. M.; Amacher, S. L.; Bertozzi, C. R.: In vivo imaging of

membrane-associated glycans in developing zebrafish. Science 2008, 320, 664-667.

103

(19)

Breidenbach, M. A.; Gallagher, J. E. G.; King, D. S.; Smart, B. P.; Wu, P.; Bertozzi,

C. R.: Targeted metabolic labeling of yeast N-glycans with unnatural sugars. Proc. Natl.
Acad. Sci. 2010, 107, 3988-3993.
(20)

Sletten, E. M.; Bertozzi, C. R.: Bioorthogonal Chemistry: Fishing for Selectivity in

a Sea of Functionality. Angew. Chem. Int. Ed. 2009, 48, 6974-6998.
(21)

Matsumoto, A.; Cabral, H.; Sato, N.; Kataoka, K.; Miyahara, Y.: Assessment of

Tumor Metastasis by the Direct Determination of Cell-Membrane Sialic Acid Expression.
Angew. Chem. Int. Ed. 2010, 49, 5494-5497.
(22)

Prescher, J. A.; Bertozzi, C. R.: Chemistry in living systems. Nat. Chem. Biol. 2005,

1, 13-21.
(23)

Dam, T. K.; Brewer, C. F.: Lectins as pattern recognition molecules: The effects of

epitope density in innate immunity. Glycobiology 2010, 20, 270-279.
(24)

Sun, X.; Zhai, W.; Fossey, J. S.; James, T. D.: Boronic acids for fluorescence

imaging of carbohydrates. Chem. Commun. 2016, 52, 3456-3469.
(25)

Ghazarian, H.; Idoni, B.; Oppenheimer, S. B.: A glycobiology review:

Carbohydrates, lectins and implications in cancer therapeutics. Acta Histochem. 2011, 113,
236-247.
(26)

James, T. D.; Phillips, M. D.; Shinkai, S.: The Molecular Recognition of

Saccharides. Complexation of Boronic Acids with Saccharides. Fluorescent Sensors.
Modular Fluorescent Sensors. Other Types of Sensor. Other Systems for Saccharide
Recognition. In Boronic Acids in Saccharide Recognition; The Royal Society of
Chemistry, 2006; pp 3-176.

104

(27)

Vandenburg, Y. R.; Zhang, Z.-Y.; Fishkind, D. J.; Smith, B. D.: Enhanced cell

binding using liposomes containing an artificial carbohydrate-binding receptor. Chem.
Commun. 2000, 149-150.
(28)

Yang, W.; Fan, H.; Gao, X.; Gao, S.; Karnati, V. V. R.; Ni, W.; Hooks, W. B.;

Carson, J.; Weston, B.; Wang, B.: The First Fluorescent Diboronic Acid Sensor Specific
for Hepatocellular Carcinoma Cells Expressing Sialyl Lewis X. Chem. Biol. 11, 439-448.
(29)

Aotake, T.; Tanimoto, H.; Hotta, H.; Kuzuhara, D.; Okujima, T.; Uno, H.; Yamada,

H.: In situ preparation of highly fluorescent pyrene-dyes from non-luminous precursors
upon photoirradiation. Chem. Commun. 2013, 49, 3661-3663.
(30)

Weigel, W.; Rettig, W.; Dekhtyar, M.; Modrakowski, C.; Beinhoff, M.; Schlüter,

A. D.: Dual Fluorescence of Phenyl and Biphenyl Substituted Pyrene Derivatives. J. Phys.
Chem. A 2003, 107, 5941-5947.
(31)

Yang, S.-W.; Elangovan, A.; Hwang, K.-C.; Ho, T.-I.: Electronic Polarization

Reversal and Excited State Intramolecular Charge Transfer in Donor/Acceptor
Ethynylpyrenes. J. Phys. Chem. B 2005, 109, 16628-16635.
(32)

Qian, X.; Xiao, Y.; Xu, Y.; Guo, X.; Qian, J.; Zhu, W.: "Alive" dyes as fluorescent

sensors: fluorophore, mechanism, receptor and images in living cells. Chem. Commun.
2010, 46, 6418-6436.

105

